KR20220018448A - Compositions containing Sargassum thunbergii extract - Google Patents
Compositions containing Sargassum thunbergii extract Download PDFInfo
- Publication number
- KR20220018448A KR20220018448A KR1020210103606A KR20210103606A KR20220018448A KR 20220018448 A KR20220018448 A KR 20220018448A KR 1020210103606 A KR1020210103606 A KR 1020210103606A KR 20210103606 A KR20210103606 A KR 20210103606A KR 20220018448 A KR20220018448 A KR 20220018448A
- Authority
- KR
- South Korea
- Prior art keywords
- extraction
- equation
- extract
- obtaining
- regression model
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 76
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 241000593522 Sargassum thunbergii Species 0.000 title claims abstract description 10
- 239000002537 cosmetic Substances 0.000 claims abstract description 25
- 239000004480 active ingredient Substances 0.000 claims abstract description 19
- 230000002087 whitening effect Effects 0.000 claims abstract description 15
- 230000037303 wrinkles Effects 0.000 claims abstract description 12
- 230000006872 improvement Effects 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 134
- 238000000605 extraction Methods 0.000 claims description 119
- 230000002401 inhibitory effect Effects 0.000 claims description 60
- 238000000540 analysis of variance Methods 0.000 claims description 44
- 102000003425 Tyrosinase Human genes 0.000 claims description 39
- 108060008724 Tyrosinase Proteins 0.000 claims description 39
- 102000029816 Collagenase Human genes 0.000 claims description 36
- 108060005980 Collagenase Proteins 0.000 claims description 36
- 229960002424 collagenase Drugs 0.000 claims description 36
- 230000004044 response Effects 0.000 claims description 32
- 229930003935 flavonoid Natural products 0.000 claims description 31
- 150000002215 flavonoids Chemical class 0.000 claims description 31
- 235000017173 flavonoids Nutrition 0.000 claims description 31
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 31
- 235000013824 polyphenols Nutrition 0.000 claims description 31
- 230000002292 Radical scavenging effect Effects 0.000 claims description 28
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 20
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 claims description 17
- 239000006228 supernatant Substances 0.000 claims description 17
- 230000036541 health Effects 0.000 claims description 16
- 239000002904 solvent Substances 0.000 claims description 15
- 235000013376 functional food Nutrition 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 230000005764 inhibitory process Effects 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 239000012046 mixed solvent Substances 0.000 claims description 8
- 238000005211 surface analysis Methods 0.000 claims description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 238000005457 optimization Methods 0.000 claims description 6
- OBIOZWXPDBWYHB-UHFFFAOYSA-N Nobiletin Natural products C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 OBIOZWXPDBWYHB-UHFFFAOYSA-N 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- MRIAQLRQZPPODS-UHFFFAOYSA-N nobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 MRIAQLRQZPPODS-UHFFFAOYSA-N 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 2
- 238000009210 therapy by ultrasound Methods 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 abstract description 15
- 230000000694 effects Effects 0.000 description 26
- 210000003491 skin Anatomy 0.000 description 24
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 14
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 14
- 239000003963 antioxidant agent Substances 0.000 description 13
- 235000006708 antioxidants Nutrition 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 238000002835 absorbance Methods 0.000 description 12
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 11
- 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 11
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 11
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 11
- 101710173693 Short transient receptor potential channel 1 Proteins 0.000 description 11
- LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 11
- 239000006210 lotion Substances 0.000 description 11
- 238000002137 ultrasound extraction Methods 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 230000003247 decreasing effect Effects 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 102000008186 Collagen Human genes 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 8
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 229920001436 collagen Polymers 0.000 description 8
- 239000006071 cream Substances 0.000 description 8
- 238000013461 design Methods 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 7
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 7
- 239000002131 composite material Substances 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- -1 ethanol Chemical compound 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000003086 colorant Substances 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 230000011382 collagen catabolic process Effects 0.000 description 4
- 239000000469 ethanolic extract Substances 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000003642 reactive oxygen metabolite Substances 0.000 description 4
- 230000009759 skin aging Effects 0.000 description 4
- 230000036560 skin regeneration Effects 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 229960004441 tyrosine Drugs 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- YFTGOBNOJKXZJC-UHFFFAOYSA-N 5,6-dihydroxyindole-2-carboxylic acid Chemical compound OC1=C(O)C=C2NC(C(=O)O)=CC2=C1 YFTGOBNOJKXZJC-UHFFFAOYSA-N 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 3
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 3
- 241000204316 Calyptraea lichen Species 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 229960000458 allantoin Drugs 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 238000009739 binding Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- SNPLKNRPJHDVJA-UHFFFAOYSA-N dl-panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 3
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 2
- WLJYNHBZKOQNNI-UHFFFAOYSA-N 5-(diaminomethylideneamino)-2-[[1-[2-[[4-methyl-2-[[1-[(4-phenyldiazenylphenyl)methoxycarbonyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]pentanoic acid Chemical compound C1CCC(C(=O)NC(CCCN=C(N)N)C(O)=O)N1C(=O)CNC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)OCC(C=C1)=CC=C1N=NC1=CC=CC=C1 WLJYNHBZKOQNNI-UHFFFAOYSA-N 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 2
- 101710093778 L-dopachrome tautomerase Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 101710173694 Short transient receptor potential channel 2 Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 229940079894 benzophenone-9 Drugs 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000020510 functional beverage Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- FXURFKFOPCZEKG-UHFFFAOYSA-N indole-5,6-quinone-2-carboxylic acid Chemical compound O=C1C(=O)C=C2NC(C(=O)O)=CC2=C1 FXURFKFOPCZEKG-UHFFFAOYSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 230000003061 melanogenesis Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- 230000002940 repellent Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000010993 response surface methodology Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- VUYXVWGKCKTUMF-UHFFFAOYSA-N tetratriacontaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO VUYXVWGKCKTUMF-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- VKUYLANQOAKALN-UHFFFAOYSA-N 2-[benzyl-(4-methoxyphenyl)sulfonylamino]-n-hydroxy-4-methylpentanamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N(C(CC(C)C)C(=O)NO)CC1=CC=CC=C1 VKUYLANQOAKALN-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- 102100026802 72 kDa type IV collagenase Human genes 0.000 description 1
- 101710151806 72 kDa type IV collagenase Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102100027998 Macrophage metalloelastase Human genes 0.000 description 1
- 101710187853 Macrophage metalloelastase Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 102100030416 Stromelysin-1 Human genes 0.000 description 1
- 101710108790 Stromelysin-1 Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 102000036861 Zinc-dependent endopeptidases Human genes 0.000 description 1
- 108091006982 Zinc-dependent endopeptidases Proteins 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000002361 compost Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- JGBUYEVOKHLFID-UHFFFAOYSA-N gelred Chemical compound [I-].[I-].C=1C(N)=CC=C(C2=CC=C(N)C=C2[N+]=2CCCCCC(=O)NCCCOCCOCCOCCCNC(=O)CCCCC[N+]=3C4=CC(N)=CC=C4C4=CC=C(N)C=C4C=3C=3C=CC=CC=3)C=1C=2C1=CC=CC=C1 JGBUYEVOKHLFID-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 239000012035 limiting reagent Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/82—Preparation or application process involves sonication or ultrasonication
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Microbiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 지충이(Sargassum thunbergii) 초음파 추출물을 유효성분으로 포함하는 피부 미백 및 주름 개선용 화장료 조성물 및 건강기능식품에 관한 것이다.The present invention relates to a cosmetic composition and health functional food for skin whitening and wrinkle improvement comprising an ultrasonic extract of Sargassum thunbergii as an active ingredient.
최근 현대인들의 소득증대에 따라 미용과 건강에 대한 관심이 증가하고 있으며, 이에 따라 기능성 향상을 목적으로 하는 합성 및 천연물 소재에 대한 개발 연구가 활발해지고 있다. 상기 합성 및 천연물 소재에 대한 항균, 항산화, 피부 노화 억제, 보습 및 미백 효과 등의 기능성이 입증되면서 신규 소재에 대한 탐색과 소요가 증가하고 있다. Recently, interest in beauty and health is increasing with the increase in income of modern people, and accordingly, research on the development of synthetic and natural materials for the purpose of improving functionality is active. As functionalities such as antibacterial, antioxidant, skin aging suppression, moisturizing and whitening effects for the synthetic and natural materials have been proven, the search for and demand for new materials is increasing.
특히 피부 미백 효과와 관련하여 멜라닌은 멜라노사이트에서 분비되는 흑색 또는 갈색 색소를 총칭하며, 멜라닌 합성은 멜라노좀 내에 존재하는 티로시나제의 작용을 통해 이루어진다. 티로시나제는 수산화 반응과 연이은 산화 반응을 통해 L-티로신으로부터 도파크롬까지의 변환과정을 촉매한다. 반면, TRP-2는 도파크롬을 이성화하여 5,6-dihydroxyindole-2-carboxylic acid(DHICA)를 생성하고, TRP-1은 DHICA를 산화시켜 indole-5,6-quinone2-carboxylic acid(IQCA)를 생성하여 페오멜라닌과 유멜라닌의 합성에 관여한다. 따라서 티로시나제, TRP-1 또는 TRP-2의 발현이 억제되면 미백효과를 기대할 수 있다.In particular, in relation to the skin whitening effect, melanin is a generic term for black or brown pigments secreted from melanocytes, and melanin synthesis is achieved through the action of tyrosinase present in melanosomes. Tyrosinase catalyzes the conversion of L-tyrosine to dopachrome through hydroxylation and subsequent oxidation. On the other hand, TRP-2 isomerizes dopachrome to produce 5,6-dihydroxyindole-2-carboxylic acid (DHICA), and TRP-1 oxidizes DHICA to produce indole-5,6-quinone2-carboxylic acid (IQCA). It is involved in the synthesis of pheomelanin and eumelanin. Therefore, when the expression of tyrosinase, TRP-1 or TRP-2 is suppressed, a whitening effect can be expected.
또한, 피부 진피층까지 침투가 가능한 자외선에 의해 활성산소종(reactive oxygen species, ROS)이 생성되면 티로시나제가 매개하는 티로신의 산화가 촉진되고 이에 멜라닌 형성이 가속화된다는 기작이 밝혀지면서 ROS를 제거하는 것이 멜라닌색소 형성억제에 효과적이라 보고되고 있다. In addition, when reactive oxygen species (ROS) are generated by ultraviolet rays that can penetrate to the dermis of the skin, the oxidation of tyrosine mediated by tyrosinase is promoted and the mechanism of melanin formation is accelerated. It is reported to be effective in inhibiting pigment formation.
한편, 피부 진피층에 존재하는 콜라겐은 엘라스틴과의 결합을 통해 피부에 가해지는 압력이나 외부의 자극으로부터 피부를 보호하는 역할과 함께 주름과 피부노화를 방지하는 중요한 세포 내 기질로 알려져 있으나, 체내 ROS가 과도하게 생성 될 경우 기질금속단백질분해효소(matrix metalloproteinase, MMP)의 일종인 콜라게나제의 활성이 증가하여 콜라겐 분해가 촉진됨에 따라 피부주름 및 탄성저하가 발생하게 된다.On the other hand, collagen present in the dermal layer of the skin is known as an important intracellular matrix that protects the skin from pressure or external stimuli applied to the skin through binding with elastin and prevents wrinkles and skin aging. When excessively produced, the activity of collagenase, a type of matrix metalloproteinase (MMP), increases, and collagen degradation is promoted, resulting in skin wrinkles and loss of elasticity.
상기 기질금속단백질분해효소(MMP)는 대식 세포(Macrophage), 섬유아세포(Fibroblast), 골세포(Born cell)와 같은 세포로부터 분비되는 칼슘 및 아연 의존성 엔도펩티다제(Endopeptidase)이며, 노화와 자외선 노출에 의해 체내에서 분비되어 피부의 세포외 기질 단백질인 콜라겐, 엘라스틴 등을 분해하는 효소이다. 그 종류는 MMP 1 ~ 28까지 존재하며 이 중에서 노화와 관련된 기질금속단백질분해효소는 MMP-1, MMP-2, MMP-3, MMP-9, MMP-12이다. 특히, MMP-1은 피부에 가장 많이 존재하는 제1형 콜라겐(type Ⅰ collagen) 가교결합의 중간을 절단하고 MMP-9은 절단된 콜라겐을 세분화하여 다시 절단하는 역할을 하기 때문에 MMP-1과 MMP-9가 피부노화 방지에 있어 집중적으로 연구된다.The matrix metalloproteinase (MMP) is a calcium and zinc-dependent endopeptidase secreted from cells such as macrophages, fibroblasts, and bone cells, and aging and UV rays It is an enzyme that is secreted from the body through exposure and breaks down collagen and elastin, the extracellular matrix proteins of the skin. The types exist from
이와 같이, 색소침착과 피부 노화를 일으키는 공통된 원인은 ROS의 축적으로서, 체내의 항산화 연쇄반응을 교란하여 세포와 조직에 비가역적인 손상을 초래하는데, 이러한 ROS 제거를 위해 항산화제를 사용하여 피부 조직을 보호할 필요성이 있다. As such, the common cause of pigmentation and skin aging is the accumulation of ROS, which disrupts the antioxidant chain reaction in the body and causes irreversible damage to cells and tissues. there is a need to protect
국내에서는 산화 방지제로서 butylated hydroxytoluene(BHT)과 butylated hydroxyanisole(BHA) 등의 합성 항산화제를 널리 사용하고 있지만, 상기 산화 방지제가 암 유발, 지방 변이 및 간 비대 등과 같은 문제를 발생시켜 보다 안전하고 활성이 높은 신규 항산화제 개발이 요구되고 있으며, 최근 합성 항산화제의 대체제로서 폴리페놀이 주목받고 있다. 상기 폴리페놀은 식물체가 생산하는 2차 대사산물로서 다수의 수산기를 가지며 수산기의 치환을 통해 ROS를 안정화시켜 체내에서 효과적으로 산화적 손상을 예방할 수 있다고 알려져 있다. 이에 따라 육상식물에서부터 폴리페놀을 추출하여 상업적으로 이용하는 연구가 활발히 이루어지고 있으나, 원료 수급에 한계가 있어 다양한 생물종과 색소물질을 가진 해조류를 이용한 천연 항산화제 생산에 대한 수요가 높아지는 현실이다.Although synthetic antioxidants such as butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA) are widely used as antioxidants in Korea, these antioxidants cause problems such as cancer induction, fat mutation, and liver enlargement, making them safer and more active. The development of high novel antioxidants is required, and polyphenols have recently been attracting attention as an alternative to synthetic antioxidants. It is known that the polyphenol is a secondary metabolite produced by a plant and has a number of hydroxyl groups and can effectively prevent oxidative damage in the body by stabilizing ROS through the substitution of hydroxyl groups. Accordingly, research on extracting polyphenols from terrestrial plants and using them commercially is actively conducted, but there is a limit to the supply and demand of raw materials, so the demand for natural antioxidant production using seaweeds with various biological species and pigments is increasing.
한편, 지충이는 예로부터 구충제로 사용되어 왔으며 식용하거나 퇴비로도 사용된다.On the other hand, worms have been used as repellents since ancient times, and they are also used as food or compost.
상업화를 위해 지충이를 이용하여 항산화 효과가 우수하고, 피부 미백 및 피부 재생에 효과적인 조성물이 요구되고 있다.For commercialization, there is a need for a composition that has excellent antioxidant effect and is effective for skin whitening and skin regeneration by using lichen.
본 발명의 목적은 지충이 초음파 추출물을 유효성분으로 포함하는 화장료 조성물을 제공하는데 있다.It is an object of the present invention to provide a cosmetic composition comprising the ultrasonic extract of worms as an active ingredient.
또한, 본 발명의 다른 목적은 지충이 초음파 추출물을 유효성분으로 포함하는 건강기능식품을 제공하는데 있다.In addition, another object of the present invention is to provide a health functional food containing the ultrasonic extract of worms as an active ingredient.
또한, 본 발명의 또 다른 목적은 지충이 초음파 추출물을 제조하는 방법을 제공하는데 있다.In addition, another object of the present invention is to provide a method for preparing an ultrasonic extract of worms.
상기한 목적을 달성하기 위한 본 발명의 피부 미백 및 주름 개선용 화장료 조성물은 지충이(Sargassum thunbergii) 초음파 추출물을 유효성분으로 포함할 수 있다.The cosmetic composition for skin whitening and wrinkle improvement of the present invention for achieving the above object may include Sargassum thunbergii ultrasonic extract as an active ingredient.
상기 지충이 초음파 추출물은 물, 탄소수 1 내지 4의 저급알코올 또는 이들의 혼합용매 하에서 추출된 것일 수 있다.The ultrasonic worm extract may be extracted under water, a lower alcohol having 1 to 4 carbon atoms, or a mixed solvent thereof.
상기 혼합용매는 20 내지 99.5 부피%의 메탄올, 에탄올, 부탄올 또는 프로판올 수용액일 수 있다.The mixed solvent may be an aqueous solution of 20 to 99.5% by volume of methanol, ethanol, butanol or propanol.
상기 지충이 초음파 추출물은 20 내지 50 kHz 진동수의 초음파기로 5 내지 30분 동안 처리된 것일 수 있다.The ultrasonic worm extract may be processed for 5 to 30 minutes with an ultrasonicator having a frequency of 20 to 50 kHz.
상기 초음파 처리 시 추출온도는 20 내지 85 ℃일 수 있다.The extraction temperature during the ultrasonic treatment may be 20 to 85 ℃.
상기 지충이 초음파 추출물의 지표물질은 노빌레틴(nobiletin)일 수 있다.The indicator material of the ultrasonic extract of worms may be nobiletin.
또한, 상기한 다른 목적을 달성하기 위한 본 발명의 피부 미백 및 주름의 예방 또는 완화용 건강기능식품은 지충이(Sargassum thunbergii) 초음파 추출물을 유효성분으로 포함할 수 있다.In addition, the health functional food for preventing or alleviating skin whitening and wrinkles of the present invention for achieving the above other object may include Sargassum thunbergii ultrasonic extract as an active ingredient.
또한, 상기한 또 다른 목적을 달성하기 위한 본 발명의 지충이 초음파 추출물의 제조방법은 (A) 물, 탄소수 1 내지 4의 저급알코올 또는 이들의 혼합용매인 추출용매, 20 내지 85 ℃의 추출온도, 5 내지 30분의 추출시간의 추출조건 하에서 20 내지 50 kHz의 진동수의 초음파기로 추출한 후 원심분리하여 수득한 상등액의 총 폴리페놀 함량에 대한 실험값을 획득하는 단계; (B) 상기 (A)단계의 실험값을 이용하여 하기 [수학식 1]로 표시되는 2차 회귀식 모델을 도출하는 단계; (C) 상기 (B)단계에서 도출된 2차 회귀식 모델을 변량분석(ANOVA)하여 신뢰도를 입증하고 상기 추출조건에 대한 반응표면곡선을 수득하는 단계; (D) 상기 (A)단계에서 수득한 상등액의 총 플라보노이드 함량에 대한 실험값을 획득하는 단계; (E) 상기 (D)단계의 실험값을 이용하여 하기 [수학식 2]로 표시되는 2차 회귀식 모델을 도출하는 단계; (F) 상기 (E)단계에서 도출된 2차 회귀식 모델을 변량분석(ANOVA)하여 신뢰도를 입증하고 상기 추출조건에 대한 반응표면곡선을 수득하는 단계; (G) 상기 (A)단계에서 수득한 상등액의 DPPH 라디칼 소거능에 대한 실험값을 획득하는 단계; (H) 상기 (G)단계의 실험값을 이용하여 하기 [수학식 3]으로 표시되는 2차 회귀식 모델을 도출하는 단계; (I) 상기 (H)단계에서 도출된 2차 회귀식 모델을 변량분석(ANOVA)하여 신뢰도를 입증하고 상기 추출조건에 대한 반응표면곡선을 수득하는 단계; (J) 상기 (A)단계에서 수득한 상등액의 티로시나제 억제능에 대한 실험값을 획득하는 단계; (K) 상기 (J)단계의 실험값을 이용하여 하기 [수학식 4]로 표시되는 2차 회귀식 모델을 도출하는 단계; (L) 상기 (K)단계에서 도출된 2차 회귀식 모델을 변량분석(ANOVA)하여 신뢰도를 입증하고 상기 추출조건에 대한 반응표면곡선을 수득하는 단계; (M) 상기 (A)단계에서 수득한 상등액의 콜라게나제 억제능에 대한 실험값을 획득하는 단계; (N) 상기 (M)단계의 실험값을 이용하여 하기 [수학식 5]로 표시되는 2차 회귀식 모델을 도출하는 단계; (O) 상기 (M)단계에서 도출된 2차 회귀식 모델을 변량분석(ANOVA)하여 신뢰도를 입증하고 상기 추출조건에 대한 반응표면곡선을 수득하는 단계; 및 (P) 상기 (C), (F), (I), (L) 및 (O)단계에서 수득된 반응표면곡선을 겹치기기법(superimposing)으로 총 폴리페놀 함량, 총 플라보노이드 함량, DPPH 라디칼 소거능, 티로시나제 억제능 및 콜라게나제 억제능에 대한 공통의 최적화 조건을 예측하는 단계;를 포함할 수 있다;In addition, the method for preparing the ultrasonic extract of worms of the present invention for achieving the above another object is (A) an extraction solvent that is water, a lower alcohol having 1 to 4 carbon atoms or a mixed solvent thereof, and an extraction temperature of 20 to 85 ℃ , obtaining experimental values for the total polyphenol content of the supernatant obtained by centrifugation after extraction with an ultrasonicator at a frequency of 20 to 50 kHz under extraction conditions of an extraction time of 5 to 30 minutes; (B) deriving a quadratic regression model represented by the following [Equation 1] using the experimental value of step (A); (C) verifying reliability by performing analysis of variance (ANOVA) on the quadratic regression model derived in step (B), and obtaining a response surface curve for the extraction conditions; (D) obtaining an experimental value for the total flavonoid content of the supernatant obtained in step (A); (E) deriving a quadratic regression model represented by the following [Equation 2] using the experimental value of step (D); (F) verifying reliability by performing analysis of variance (ANOVA) on the quadratic regression model derived in step (E), and obtaining a response surface curve for the extraction conditions; (G) obtaining an experimental value for the DPPH radical scavenging ability of the supernatant obtained in step (A); (H) deriving a quadratic regression model represented by the following [Equation 3] using the experimental values of the step (G); (I) verifying reliability by performing analysis of variance (ANOVA) on the quadratic regression model derived in step (H), and obtaining a response surface curve for the extraction conditions; (J) obtaining an experimental value for the tyrosinase inhibitory ability of the supernatant obtained in step (A); (K) deriving a quadratic regression model represented by the following [Equation 4] using the experimental values of the step (J); (L) verifying reliability by performing analysis of variance (ANOVA) on the quadratic regression model derived in step (K), and obtaining a response surface curve for the extraction conditions; (M) obtaining an experimental value for the collagenase inhibitory ability of the supernatant obtained in step (A); (N) deriving a quadratic regression model represented by the following [Equation 5] using the experimental values of the step (M); (O) verifying reliability by performing analysis of variance (ANOVA) on the quadratic regression model derived in step (M), and obtaining a response surface curve for the extraction conditions; and (P) total polyphenol content, total flavonoid content, and DPPH radical scavenging ability by superimposing the reaction surface curves obtained in steps (C), (F), (I), (L) and (O). , predicting common optimization conditions for tyrosinase inhibitory ability and collagenase inhibitory ability; may include;
[수학식 1][Equation 1]
YTPC=+11.87710-0.27813X1+0.062526X2-0.10999X3-0.038357X1 2+0.011033X1X2-8.04762E-004X2 2+9.16875E-003X1X3-2.72059E-004X2X3-9.82967E-004X3 2 Y TPC =+11.87710-0.27813X 1 +0.062526X 2 -0.10999X 3 -0.038357X 1 2 +0.011033X 1 X 2 -8.04762E-004X 2 2 +9.16875E-003X 1 X 3 -2.72059E-004X 2 X 3 -9.82967E-004X 3 2
[수학식 2][Equation 2]
YTFC=+0.29505-0.027059X1-3.97311E-003X2+2.06369E-003X3+6.56102E-004X1 2+2.35575E-004X1X2+1.4523E-005X2 2-5.60826E-005X1X3+4.47917E-005X2X3-9.59741E-006X3 2 Y TFC =+0.29505-0.027059X 1 -3.97311E-003X 2 +2.06369E-003X 3 +6.56102E-004X 1 2 +2.35575E-004X 1 X 2 +1.4523E-005X 2 2 -5.60826E-005X 1 X 3 +4.47917E-005X 2 X 3 -9.59741E-006X 3 2
[수학식 3][Equation 3]
YDPPH=-12.01377-0.23738X1+1.10578X2+1.88331X3-0.18487X1 2+0.065359X1X2-0.015823X2 2+0.018519X1X3+6.53596E-003X2X3-0.027340X3 2 Y DPPH =-12.01377-0.23738X 1 +1.10578X 2 +1.88331X 3 -0.18487X 1 2 +0.065359X 1 X 2 -0.015823X 2 2 +0.018519X 1 X 3 +6.53596E-003X 2 X 3 -0.027340X 3 2
[수학식 4][Equation 4]
YTI=+21.89570+2.31910X1+0.73168X2+0.89582X3-0.10956X1 2+6.37868E-003X1X2-7.16647E-003X2 2-1.71875E-003X1X3+2.17402E-003X2X3-7.54092EX3 2 Y TI =+21.89570+2.31910X 1 +0.73168X 2 +0.89582X 3 -0.10956X 1 2 +6.37868E-003X 1 X 2 -7.16647E-003X 2 2 -1.71875E-003X 1 X 3 +2.17402E-003X 2 X 3 -7.54092EX 3 2
[수학식 5][Equation 5]
YCI=7.18898+0.47210X1+1.74516X2+1.05430X3-0.20030X1 2+0.036374X1X2-0.013524X2 2+0.042529X1X3-7.41903E-003X2X3-8.53821E-003X3 2 Y CI =7.18898+0.47210X 1 +1.74516X 2 +1.05430X 3 -0.20030X 1 2 +0.036374X 1 X 2 -0.013524X 2 2 +0.042529X 1 X 3 -7.41903E-003X 2 X 3 -8.53821E- 003X 3 2
상기 수학식 1 내지 5에서, YTPC는 총 폴리페놀 함량(mg GAE/g DM), YTFC는 총 플라보노이드 함량(mg QE/g DM), YDPPH는 DPPH 라디칼 소거능 예측값(%), YTI는 티로시나제 억제능 예측값(%), YCI는 콜라게나제 억제능 예측값(%), X1은 추출시간, X2는 추출온도, X3는 추출용매의 농도이다.In
상기 DPPH 라디칼 소거능, 총 폴리페놀 함량, 총 플라보노이드 함량, 티로시나제 억제능 및 콜라게나제 억제능에 대한 공통의 최적화 조건에 따른 추출조건은 추출 시간 11.0분, 추출 온도 81.5 ℃ 및 에탄올 농도 50 부피%인 것일 수 있다.Extraction conditions according to common optimization conditions for the DPPH radical scavenging ability, total polyphenol content, total flavonoid content, tyrosinase inhibitory ability and collagenase inhibitory ability are extraction time of 11.0 minutes, extraction temperature of 81.5 ° C., and ethanol concentration of 50% by volume. have.
본 발명의 지충이 초음파 추출물을 포함하는 조성물은 독성이 없으며, 항산화 효과가 우수하고, 피부 미백 및 피부 재생에 효과적이다.The composition comprising the worm worm ultrasonic extract of the present invention is non-toxic, has excellent antioxidant effect, and is effective for skin whitening and skin regeneration.
또한, 총 폴리페놀 함량, 총 플라보노이드 함량, DPPH 라디칼 소거능, 티로시나제 억제능 및 콜라게나제 억제능이 증가된 지충이 초음파 추출물을 수득할 수 있다.In addition, it is possible to obtain an ultrasonic worm extract with increased total polyphenol content, total flavonoid content, DPPH radical scavenging ability, tyrosinase inhibitory activity and collagenase inhibitory activity.
뿐만 아니라, 반응표면분석법(response surface methodology, RSM)을 이용하여 초음파 추출(ultrasound-assisted extraction, UAE) 조건을 최적화함으로써, 생리활성 물질의 수율 증대를 수행하였다. In addition, by optimizing ultrasonic-assisted extraction (UAE) conditions using response surface methodology (RSM), the yield of bioactive substances was increased.
도 1은 본 발명의 실시예에 따라 제조된 지충이 초음파 추출물을 이용 시 총 폴리페놀 함량(TPC)에 영향을 미치는 조건을 나타낸 일변수 곡선이다.
도 2는 본 발명의 실시예에 따라 제조된 지충이의 초음파 추출 조건에 따른 총 폴리페놀 함량(TPC)의 3차원 반응표면곡선이다.
도 3은 본 발명의 실시예에 따라 제조된 지충이 초음파 추출물을 이용 시 총 플라보노이드 함량(TFC)에 영향을 미치는 조건을 나타낸 일변수 곡선이다.
도 4는 본 발명의 실시예에 따라 제조된 지충이의 초음파 추출 조건에 따른 총 플라보노이드 함량(TFC)의 3차원 반응표면곡선이다.
도 5는 본 발명의 실시예에 따라 제조된 지충이 초음파 추출물을 이용 시 DPPH 라디칼 소거능(DSA)에 영향을 미치는 조건을 나타낸 일변수 곡선이다.
도 6은 본 발명의 실시예에 따라 제조된 지충이의 초음파 추출 조건에 따른 DPPH 라디칼 소거능(DSA)의 3차원 반응표면곡선이다.
도 7은 본 발명의 실시예에 따라 제조된 지충이 초음파 추출물을 이용 시 티로시나제 억제능(TIA)에 영향을 미치는 조건을 나타낸 일변수 곡선이다.
도 8은 본 발명의 실시예에 따라 제조된 지충이의 초음파 추출 조건에 따른 티로시나제 억제능(TIA)의 3차원 반응표면곡선이다.
도 9는 본 발명의 실시예에 따라 제조된 지충이 초음파 추출물을 이용 시 콜라게나제 억제능(CIA)에 영향을 미치는 조건을 나타낸 일변수 곡선이다.
도 10은 본 발명의 실시예에 따라 제조된 지충이의 초음파 추출 조건에 따른 콜라게나제 억제능(CIA)의 3차원 반응표면곡선이다.
도 11은 본 발명의 실시예에 따라 제조된 지충이의 초음파 최적 추출조건을 찾기 위하여 상기 도 2, 도 4, 도 6, 도 8 및 도 10의 반응표면곡선을 겹치기기법으로 나타낸 그래프이다.
도 12는 본 발명의 실시예 12에 따라 제조된 지충이 초음파 추출물의 지표물질을 측정한 NMR데이터이다.1 is a univariate curve showing the conditions in which worms prepared according to an embodiment of the present invention affect the total polyphenol content (TPC) when using an ultrasonic extract.
2 is a three-dimensional response surface curve of the total polyphenol content (TPC) according to the ultrasonic extraction conditions of worms prepared according to an embodiment of the present invention.
Figure 3 is a univariate curve showing the conditions affecting the total flavonoid content (TFC) when using the ultrasonic extract of worms prepared according to an embodiment of the present invention.
4 is a three-dimensional response surface curve of the total flavonoid content (TFC) according to the ultrasonic extraction conditions of worms prepared according to an embodiment of the present invention.
5 is a univariate curve showing the conditions under which worms prepared according to an embodiment of the present invention affect DPPH radical scavenging ability (DSA) when using an ultrasonic extract.
6 is a three-dimensional response surface curve of the DPPH radical scavenging ability (DSA) according to the ultrasonic extraction conditions of worms prepared according to an embodiment of the present invention.
7 is a univariate curve showing the conditions under which tyrosinase inhibitory ability (TIA) is affected when worms prepared according to an embodiment of the present invention use an ultrasonic extract.
8 is a three-dimensional response surface curve of tyrosinase inhibitory ability (TIA) according to ultrasonic extraction conditions of worms prepared according to an embodiment of the present invention.
9 is a univariate curve showing the conditions in which worms prepared according to an embodiment of the present invention affect collagenase inhibitory ability (CIA) when using an ultrasonic extract.
10 is a three-dimensional response surface curve of the collagenase inhibitory ability (CIA) according to the ultrasonic extraction conditions of worms prepared according to an embodiment of the present invention.
11 is a graph showing the method of overlapping the response surface curves of FIGS. 2, 4, 6, 8 and 10 in order to find the optimal ultrasonic extraction conditions for worms prepared according to an embodiment of the present invention.
12 is NMR data obtained by measuring the indicator material of the ultrasonic extract of worms prepared according to Example 12 of the present invention.
본 발명은 지충이(Sargassum thunbergii) 초음파 추출물을 유효성분으로 포함하는 피부 미백 및 주름 개선용 화장료 조성물 및 건강기능식품에 관한 것이다.The present invention relates to a cosmetic composition and health functional food for skin whitening and wrinkle improvement comprising an ultrasonic extract of Sargassum thunbergii as an active ingredient.
이하, 본 발명을 상세하게 설명한다. Hereinafter, the present invention will be described in detail.
본 발명의 화장료 조성물은 지충이 초음파 추출물을 유효성분으로 포함한다.The cosmetic composition of the present invention contains the ultrasonic worm extract as an active ingredient.
지충이(Sargassum thunbergii)는 작은 반상근에서 직립하고 곧게 뻗는 중심가지와 불규칙하게 생기는 곁가지로 되어 있는데 줄기 표면에 돌기 모양의 잎이 밀생한다. 지충이의 어린 식물은 식용하나 흔히 사료로 쓰이고, 구충제로도 쓰인 적이 있다. Sargassum thunbergii has an erect and straight central branch and irregularly formed side branches from a small semi-rectum root, and protuberance-shaped leaves are densely grown on the stem surface. Young plants of worms are edible, but are often used as feed and have been used as repellents.
상기 지충이는 추출용매 하에서 초음파처리를 통해 추출되는 것으로서, 구체적으로 지충이와 추출용매가 1 : 5 내지 25의 중량비, 바람직하게는 1 : 10 내지 20의 중량비로 혼합되어 20 내지 50 kHz, 바람직하게는 30 내지 40 kHz의 진동수 및 50 내지 700 W, 바람직하게는 150 내지 400 W 파워의 초음파기로 20 내지 85 ℃, 바람직하게는 60 내지 80 ℃하에서 5 내지 30분, 바람직하게는 10 내지 20분 동안 처리된다. The lichen is extracted through sonication under an extraction solvent, and specifically, the worm and the extraction solvent are mixed in a weight ratio of 1: 5 to 25, preferably 1: 10 to 20, and 20 to 50 kHz, preferably Preferably at a frequency of 30 to 40 kHz and an ultrasonic wave of 50 to 700 W, preferably 150 to 400 W power at 20 to 85 °C, preferably 60 to 80 °C for 5 to 30 minutes, preferably 10 to 20 minutes processed while
지충이를 추출 시 초음파 추출이 아니라 열수 추출, 에탄올 등의 알코올 추출인 경우에는 유효성분이 소량 추출될 뿐만 아니라 항산화, 피부미백 및 피부재생 효과가 낮을 수 있다.In the case of extraction with hot water or alcohol such as ethanol, not ultrasonic extraction, not only a small amount of active ingredients are extracted, but also antioxidant, skin whitening and skin regeneration effects may be low.
상기 지충이와 추출용매의 중량비가 상기 범위를 벗어나는 경우에는 추출물에 지충이의 유효성분이 적은 양으로 추출될 수 있다. When the weight ratio of the lichen and the extraction solvent is out of the above range, the active ingredient of the lichen may be extracted in a small amount in the extract.
또한, 초음파기의 진동수 및 파워가 상기 하한치 미만인 경우에는 지충이의 유효성분이 적은 양으로 추출될 수 있으며, 상기 상한치 초과인 경우에는 유효성분 외에 다른 물질도 다량으로 추출되어 효과가 저하될 수 있다. In addition, when the frequency and power of the ultrasonicator are less than the lower limit, the active ingredient of the lichen may be extracted in a small amount, and if it exceeds the upper limit, other substances in addition to the active ingredient are extracted in a large amount, thereby reducing the effect.
또한, 추출온도 및 추출시간이 상기 하한치 미만인 경우에는 지충이의 유효성분이 적은 양으로 추출될 수 있으며, 상기 상한치 초과인 경우에는 독성물질이 발생할 수 있다.In addition, when the extraction temperature and extraction time are less than the lower limit, the active ingredient of the worm can be extracted in a small amount, and when it exceeds the upper limit, toxic substances may be generated.
상기 추출물을 추출하는 추출용매는 물, 탄소수 1 내지 4의 저급알코올, 에틸렌글리콜, 에틸에테르 또는 이들의 혼합용매이다. 상기 저급알코올로는 20 내지 99 부피%의 메탄올, 에탄올, 부탄올 또는 프로판올 수용액을 들 수 있으며, 바람직하게는 우수한 항산화, 피부미백 및 피부재생 효과를 위하여 30 내지 60 부피%의 에탄올 수용액을 들 수 있다.The extraction solvent for extracting the extract is water, a lower alcohol having 1 to 4 carbon atoms, ethylene glycol, ethyl ether, or a mixed solvent thereof. The lower alcohol may be an aqueous solution of methanol, ethanol, butanol or propanol in an amount of 20 to 99% by volume, and preferably an aqueous solution of 30 to 60% by volume of ethanol for excellent antioxidant, skin whitening and skin regeneration effects. .
본 발명의 지충이 초음파 추출물은 화장료 조성물 외에 건강기능식품에도 사용될 수 있다.Ultrasonic extract of C. lichen of the present invention may be used in health functional foods in addition to cosmetic compositions.
또한, 본 발명은 반응표면분석법을 이용하여 지충이 초음파 추출물을 제조하는 방법을 제공한다.In addition, the present invention provides a method for preparing an ultrasonic extract of worms using a response surface analysis method.
본 발명의 반응표면분석법을 이용한 지충이 초음파 추출물의 제조방법은 (A) 물, 탄소수 1 내지 4의 저급알코올 또는 이들의 혼합용매인 추출용매, 20 내지 85 ℃의 추출온도, 5 내지 30분의 추출시간의 추출조건 하에서 20 내지 50 kHz의 진동수 및 50 내지 700 W의 파워의 초음파기로 추출한 후 원심분리하여 수득한 상등액의 총 폴리페놀 함량에 대한 실험값을 획득하는 단계; (B) 상기 (A)단계의 실험값을 이용하여 하기 [수학식 1]로 표시되는 2차 회귀식 모델을 도출하는 단계; (C) 상기 (B)단계에서 도출된 2차 회귀식 모델을 변량분석(ANOVA)하여 신뢰도를 입증하고 상기 추출조건에 대한 반응표면곡선을 수득하는 단계; (D) 상기 (A)단계에서 수득한 상등액의 총 플라보노이드 함량에 대한 실험값을 획득하는 단계; (E) 상기 (D)단계의 실험값을 이용하여 하기 [수학식 2]로 표시되는 2차 회귀식 모델을 도출하는 단계; (F) 상기 (E)단계에서 도출된 2차 회귀식 모델을 변량분석(ANOVA)하여 신뢰도를 입증하고 상기 추출조건에 대한 반응표면곡선을 수득하는 단계; (G) 상기 (A)단계에서 수득한 상등액의 DPPH 라디칼 소거능에 대한 실험값을 획득하는 단계; (H) 상기 (G)단계의 실험값을 이용하여 하기 [수학식 3]으로 표시되는 2차 회귀식 모델을 도출하는 단계; (I) 상기 (H)단계에서 도출된 2차 회귀식 모델을 변량분석(ANOVA)하여 신뢰도를 입증하고 상기 추출조건에 대한 반응표면곡선을 수득하는 단계; (J) 상기 (A)단계에서 수득한 상등액의 티로시나제 억제능에 대한 실험값을 획득하는 단계; (K) 상기 (J)단계의 실험값을 이용하여 하기 [수학식 4]로 표시되는 2차 회귀식 모델을 도출하는 단계; (L) 상기 (K)단계에서 도출된 2차 회귀식 모델을 변량분석(ANOVA)하여 신뢰도를 입증하고 상기 추출조건에 대한 반응표면곡선을 수득하는 단계; (M) 상기 (A)단계에서 수득한 상등액의 콜라게나제 억제능에 대한 실험값을 획득하는 단계; (N) 상기 (M)단계의 실험값을 이용하여 하기 [수학식 5]로 표시되는 2차 회귀식 모델을 도출하는 단계; (O) 상기 (M)단계에서 도출된 2차 회귀식 모델을 변량분석(ANOVA)하여 신뢰도를 입증하고 상기 추출조건에 대한 반응표면곡선을 수득하는 단계; 및 (P) 상기 (C), (F), (I), (L) 및 (O)단계에서 수득된 반응표면곡선을 겹치기기법(superimposing)으로 총 폴리페놀 함량, 총 플라보노이드 함량, DPPH 라디칼 소거능, 티로시나제 억제능 및 콜라게나제 억제능에 대한 공통의 최적화 조건을 예측하는 단계;를 포함한다. 이렇게 예측된 조건을 이용하여 지충이를 초음파 추출하면 DPPH 라디칼 소거능, 총 폴리페놀 함량, 총 플라보노이드 함량, 티로시나제 억제능 및 콜라게나제 억제능에 대하여 우수한 효과를 보인다. The method for preparing an ultrasonic worm extract using the reaction surface analysis method of the present invention is (A) water, an extraction solvent that is a lower alcohol having 1 to 4 carbon atoms or a mixed solvent thereof, an extraction temperature of 20 to 85 ℃, 5 to 30 minutes Obtaining experimental values for the total polyphenol content of the supernatant obtained by centrifugation after extraction with an ultrasonicator of a frequency of 20 to 50 kHz and a power of 50 to 700 W under the extraction conditions of the extraction time; (B) deriving a quadratic regression model represented by the following [Equation 1] using the experimental value of step (A); (C) verifying reliability by performing analysis of variance (ANOVA) on the quadratic regression model derived in step (B), and obtaining a response surface curve for the extraction conditions; (D) obtaining an experimental value for the total flavonoid content of the supernatant obtained in step (A); (E) deriving a quadratic regression model represented by the following [Equation 2] using the experimental value of step (D); (F) verifying reliability by performing analysis of variance (ANOVA) on the quadratic regression model derived in step (E), and obtaining a response surface curve for the extraction conditions; (G) obtaining an experimental value for the DPPH radical scavenging ability of the supernatant obtained in step (A); (H) deriving a quadratic regression model represented by the following [Equation 3] using the experimental values of the step (G); (I) verifying reliability by performing analysis of variance (ANOVA) on the quadratic regression model derived in step (H), and obtaining a response surface curve for the extraction conditions; (J) obtaining an experimental value for the tyrosinase inhibitory ability of the supernatant obtained in step (A); (K) deriving a quadratic regression model represented by the following [Equation 4] using the experimental values of the step (J); (L) verifying reliability by performing analysis of variance (ANOVA) on the quadratic regression model derived in step (K), and obtaining a response surface curve for the extraction conditions; (M) obtaining an experimental value for the collagenase inhibitory ability of the supernatant obtained in step (A); (N) deriving a quadratic regression model represented by the following [Equation 5] using the experimental values of the step (M); (O) verifying reliability by performing analysis of variance (ANOVA) on the quadratic regression model derived in step (M), and obtaining a response surface curve for the extraction conditions; and (P) total polyphenol content, total flavonoid content, and DPPH radical scavenging ability by superimposing the reaction surface curves obtained in steps (C), (F), (I), (L) and (O). , predicting common optimization conditions for tyrosinase inhibitory ability and collagenase inhibitory ability; Ultrasonic extraction of worms using these predicted conditions shows excellent effects on DPPH radical scavenging ability, total polyphenol content, total flavonoid content, tyrosinase inhibitory ability and collagenase inhibitory ability.
[수학식 1][Equation 1]
YTPC=+11.87710-0.27813X1+0.062526X2-0.10999X3-0.038357X1 2+0.011033X1X2-8.04762E-004X2 2+9.16875E-003X1X3-2.72059E-004X2X3-9.82967E-004X3 2 Y TPC =+11.87710-0.27813X 1 +0.062526X 2 -0.10999X 3 -0.038357X 1 2 +0.011033X 1 X 2 -8.04762E-004X 2 2 +9.16875E-003X 1 X 3 -2.72059E-004X 2 X 3 -9.82967E-004X 3 2
[수학식 2][Equation 2]
YTFC=+0.29505-0.027059X1-3.97311E-003X2+2.06369E-003X3+6.56102E-004X1 2+2.35575E-004X1X2+1.4523E-005X2 2-5.60826E-005X1X3+4.47917E-005X2X3-9.59741E-006X3 2 Y TFC =+0.29505-0.027059X 1 -3.97311E-003X 2 +2.06369E-003X 3 +6.56102E-004X 1 2 +2.35575E-004X 1 X 2 +1.4523E-005X 2 2 -5.60826E-005X 1 X 3 +4.47917E-005X 2 X 3 -9.59741E-006X 3 2
[수학식 3][Equation 3]
YDPPH=-12.01377-0.23738X1+1.10578X2+1.88331X3-0.18487X1 2+0.065359X1X2-0.015823X2 2+0.018519X1X3+6.53596E-003X2X3-0.027340X3 2 Y DPPH =-12.01377-0.23738X 1 +1.10578X 2 +1.88331X 3 -0.18487X 1 2 +0.065359X 1 X 2 -0.015823X 2 2 +0.018519X 1 X 3 +6.53596E-003X 2 X 3 -0.027340X 3 2
[수학식 4][Equation 4]
YTI=+21.89570+2.31910X1+0.73168X2+0.89582X3-0.10956X1 2+6.37868E-003X1X2-7.16647E-003X2 2-1.71875E-003X1X3+2.17402E-003X2X3-7.54092EX3 2 Y TI =+21.89570+2.31910X 1 +0.73168X 2 +0.89582X 3 -0.10956X 1 2 +6.37868E-003X 1 X 2 -7.16647E-003X 2 2 -1.71875E-003X 1 X 3 +2.17402E-003X 2 X 3 -7.54092EX 3 2
[수학식 5][Equation 5]
YCI=7.18898+0.47210X1+1.74516X2+1.05430X3-0.20030X1 2+0.036374X1X2-0.013524X2 2+0.042529X1X3-7.41903E-003X2X3-8.53821E-003X3 2 Y CI =7.18898+0.47210X 1 +1.74516X 2 +1.05430X 3 -0.20030X 1 2 +0.036374X 1 X 2 -0.013524X 2 2 +0.042529X 1 X 3 -7.41903E-003X 2 X 3 -8.53821E- 003X 3 2
상기 수학식 1 내지 5에서, YTPC는 총 폴리페놀 함량(mg GAE/g DM), YTFC는 총 플라보노이드 함량(mg QE/g DM), YDPPH는 DPPH 라디칼 소거능 예측값(%), YTI는 티로시나제 억제능 예측값(%), YCI는 콜라게나제 억제능 예측값(%), X1은 추출시간, X2는 추출온도, X3는 추출용매의 농도이다.In
본 명세서에서 지충이를 언급하면서 사용되는 용어 '추출물'은 추출용매를 처리하여 얻은 조추출물뿐만 아니라 지충이 추출물의 가공물도 포함한다. 예를 들어, 지충이 초음파 추출물은 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조될 수 있다.In the present specification, the term 'extract' used while referring to C. lichen includes not only the crude extract obtained by treating the extract with an extraction solvent, but also the processed product of the C. larvae extract. For example, the ultrasonic extract of C. lichen may be prepared in a powder state by an additional process such as distillation under reduced pressure and freeze-drying or spray-drying.
한편, 본 명세서에서 용어 '유효성분으로 함유하는'이란 지충이 초음파 추출물의 효능 또는 활성을 달성하는 데 충분한 양을 포함하는 것을 의미한다. 일예로, 상기 지충이 초음파 추출물은 10 내지 1500 ㎍/㎖, 바람직하게는 100 내지 1000 ㎍/㎖의 농도로 사용된다. 지충이 초음파 추출물은 천연물로서 과량 사용하여도 인체에 부작용이 없으므로 본 발명의 조성물 내에 포함되는 지충이 초음파 추출물의 양적 상한은 당업자가 적절한 범위 내에서 선택하여 실시할 수 있다.Meanwhile, in the present specification, the term 'contained as an active ingredient' means that the worm includes an amount sufficient to achieve the efficacy or activity of the ultrasonic extract. As an example, the ultrasonic extract of L. worms is used at a concentration of 10 to 1500 μg/ml, preferably 100 to 1000 μg/ml. Since the ultrasonic worm worm extract is a natural product and there is no side effect on the human body even when used in excess, the upper limit of the quantitative upper limit of the worm worm ultrasonic extract contained in the composition of the present invention can be selected and carried out by those skilled in the art within an appropriate range.
본 발명의 화장료 조성물에는 상기의 화장료 조성물과 더불어 필요에 따라 통상 화장료에 배합되는 다른 성분을 배합할 수 있으며, 이러한 배합 성분으로서는 유지 성분, 보습제, 에몰리엔트제, 계면 활성제, 유기 및 무기 안료, 유기 분체, 자외선 흡수제, 방부제, 살균제, 산화 방지제, pH 조정제, 알콜, 색소, 향료, 혈행 촉진제, 냉감제, 제한제, 정제수, 수용성 비타민, 지용성 비타민, 고분자 펩티드, 고분자 다당, 스핑고 지질 및 해초 엑기스 등을 들 수 있다.In the cosmetic composition of the present invention, in addition to the above cosmetic composition, other ingredients commonly formulated in cosmetics may be blended as needed. Examples of these blending ingredients include oil and fat ingredients, moisturizing agents, emollients, surfactants, organic and inorganic pigments, Organic powder, UV absorber, preservative, disinfectant, antioxidant, pH adjuster, alcohol, colorant, flavoring agent, blood circulation promoter, cooling agent, limiting agent, purified water, water-soluble vitamin, fat-soluble vitamin, polymer peptide, polymer polysaccharide, sphingolipid and seaweed an extract, etc. are mentioned.
본 발명의 화장료 조성물은 당업계에서 통상 사용되는 유화 제형 및 가용화 제형의 형태로 제조될 수 있다.The cosmetic composition of the present invention may be prepared in the form of emulsified formulations and solubilized formulations commonly used in the art.
또한, 본 발명의 상기 화장료 조성물에 포함되는 성분은 유효성분으로서 상기 성분 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예를 들면, 안정화제, 안료 및 천연향료와 같은 통상적인 보조제 및 담체를 더 포함할 수 있다.In addition, the ingredients included in the cosmetic composition of the present invention may include ingredients commonly used in cosmetic compositions in addition to the ingredients as active ingredients, for example, conventional adjuvants such as stabilizers, pigments and natural fragrances; It may further include a carrier.
본 발명의 조성물을 첨가할 수 있는 제품으로는, 예를 들어, 미스트, 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사지크림, 영양크림, 자외선 차단크림, 모이스처크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 마스크팩, 프레스파우더, 루스파우더, 아이섀도우 등과 같은 화장품류와 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클린저 등이 있다.Products to which the composition of the present invention can be added include, for example, mist, skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nourishing lotion, massage cream, nourishing cream, sunscreen cream , moisture cream, hand cream, foundation, essence, nourishing essence, mask pack, press powder, loose powder, eye shadow, etc., and soap, cleansing foam, cleansing lotion, cleansing cream, body lotion and body cleanser.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal fiber, vegetable fiber, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as a carrier component. can
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판, 부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In particular, in the case of a spray, additional chlorofluorohydrocarbon, propane , butane or propellants such as dimethyl ether.
본 발명의 제형이 용액 또는 유탁액의 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solvating agent or emulsifying agent is used as a carrier component, for example, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 ,3-butylglycol oil, glycerol fatty esters, fatty acid esters of polyethylene glycol or sorbitan.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the present invention is a suspension, as a carrier component, water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline Cellulose, aluminum metahydroxide, bentonite, agar or tracanth may be used.
또한, 본 발명은 지충이 초음파 추출물을 유효성분으로 함유하는 건강기능식품 조성물을 제공한다.In addition, the present invention provides a health functional food composition containing the ultrasonic extract of worms as an active ingredient.
건강기능식품이란, 지충이 초음파 추출물을 음료, 차류, 향신료, 껌, 과자류 등의 식품소재에 첨가하거나, 캡슐화, 분말화, 현탁액 등으로 제조한 식품으로, 이를 섭취할 경우 건강상 특정한 효과를 가져오는 것을 의미하나, 일반 약품과는 달리 식품을 원료로 하여 약품의 장기 복용시 발생할 수 있는 부작용 등이 없는 장점이 있다. 이와 같이 하여 얻어지는 본 발명의 건강기능식품은, 일상적으로 섭취하는 것이 가능하기 때문에 매우 유용하다. 이와 같은 건강기능식품에 있어서의 지충이 초음파 추출물의 첨가량은, 대상인 건강기능식품의 종류에 따라 달라 일률적으로 규정할 수 없지만, 식품 본래의 맛을 손상시키지 않는 범위에서 첨가하면 되며, 대상 식품에 대하여 통상 0.01 내지 50 중량%, 바람직하기로는 0.1 내지 20 중량%의 범위이다. 또한, 환제, 과립제, 정제 또는 캡슐제 형태의 건강기능식품의 경우에는 통상 0.1 내지 100 중량% 바람직하기로는 0.5 내지 80 중량%의 범위에서 첨가하면 된다. 한 구체예에서, 본 발명의 건강기능식품은 환제, 정제, 캡슐제 또는 음료의 형태일 수 있다.Health functional food is a food prepared by adding ultrasonic extract of worms to food materials such as beverages, teas, spices, gum, and confectionery, or by encapsulating, powdering, or suspension, etc. However, unlike general medicines, it has the advantage that there are no side effects that may occur when taking the medicine for a long period of time by using food as a raw material. The health functional food of the present invention obtained in this way is very useful because it can be ingested on a daily basis. The added amount of the ultrasonic extract of worms in such health functional food cannot be uniformly defined as it varies depending on the type of health functional food, but it can be added within the range that does not impair the original taste of the food, and for the target food It is usually in the range of 0.01 to 50% by weight, preferably 0.1 to 20% by weight. In addition, in the case of a health functional food in the form of pills, granules, tablets or capsules, it is usually added in an amount of 0.1 to 100% by weight, preferably 0.5 to 80% by weight. In one embodiment, the health functional food of the present invention may be in the form of a pill, tablet, capsule or beverage.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시하나, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명의 범주 및 기술사상 범위 내에서 다양한 변경 및 수정이 가능함은 당업자에게 있어서 명백한 것이며, 이러한 변형 및 수정이 첨부된 특허청구범위에 속하는 것도 당연한 것이다.Hereinafter, preferred examples are presented to help the understanding of the present invention, but the following examples are merely illustrative of the present invention, and it will be apparent to those skilled in the art that various changes and modifications are possible within the scope and spirit of the present invention, It goes without saying that such variations and modifications fall within the scope of the appended claims.
실시예 1 내지 17. Examples 1 to 17.
파라제주(ParaJeJu. Ltd., Juju, Korea)에서 구입한 지충이를 60 ℃ 열풍건조기(FC 49, Lab house, Korea)에서 16시간 건조하여 더 이상의 중량이 낮아지지 않는 것을 확인하고 건조한 시료를 분쇄기(HMF-3000S, Hanil, Korea)로 분쇄한 후 40-100 mesh의 여과망에 통과시켜 데시케이터에서 보관하였다. 상기 분쇄된 지충이와 농도가 상이한 에탄올 수용액을 1 : 20의 중량비로 혼합하여 초음파기(JAC Ultrasinic, Hwaseng, Korea)에 투입 후 초음파(40 kHz, 200 W)를 이용하여 추출하였다. 추출한 추출물을 원심분리기를 이용하여 고액분리(4 ℃, 5000 rpm, 3분)한 후 상등액만 이용하였다.The worms purchased from ParaJeJu. Ltd., Juju, Korea were dried in a hot air dryer (FC 49, Lab house, Korea) at 60 ° C for 16 hours to confirm that the weight did not decrease any more, and the dried sample was crushed (HMF-3000S, Hanil, Korea) and then passed through a 40-100 mesh filtration net and stored in a desiccator. The pulverized worms and an aqueous ethanol solution having different concentrations were mixed in a weight ratio of 1:20, put into an ultrasonicator (JAC Ultrasinic, Hwaseng, Korea), and then extracted using ultrasonic waves (40 kHz, 200 W). The extracted extract was subjected to solid-liquid separation (4 °C, 5000 rpm, 3 minutes) using a centrifuge, and only the supernatant was used.
이때 추출 공정의 추출시간, 추출온도 및 에탄올 농도를 다르게 하여 각각의 추출물을 수득하였다. At this time, each extract was obtained by varying the extraction time, extraction temperature, and ethanol concentration of the extraction process.
비교예 1. 열수 추출물Comparative Example 1. Hot water extract
파라제주(ParaJeJu. Ltd., Juju, Korea)에서 구입한 지충이와 물을 1 : 20의 중량비로 혼합하여 80 ℃에서 20분간 동안 추출하여 지충이 열수 추출물을 수득하였다.ParaJeJu. Ltd. (ParaJeJu. Ltd., Juju, Korea) was mixed with water in a weight ratio of 1:20 and extracted at 80 °C for 20 minutes to obtain a hot water extract of worms.
비교예 2. 에탄올 추출물Comparative Example 2. Ethanol extract
파라제주(ParaJeJu. Ltd., Juju, Korea)에서 구입한 지충이와 50 부피% 에탄올 수용액을 1 : 20의 중량비로 혼합하여 80 ℃에서 20분간 동안 추출하여 지충이 에탄올 추출물을 수득하였다.ParaJeJu. Ltd. (ParaJeJu. Ltd., Juju, Korea) was mixed with a 50% by volume aqueous ethanol solution in a weight ratio of 1:20 and extracted at 80° C. for 20 minutes to obtain an ethanol extract of wormwood.
<시험예><Test Example>
실시예 1 내지 17 및 비교예 1 내지 2에 따라 제조된 추출물을 이용하여 항산화, 미백과 피부재생의 지표인 DPPH 소거능, 총 폴리페놀, 총 플라보노이드, tyrosinase inhibition activity(TIA)와 collagenase inhibition activity(CIA)를 측정하였다.DPPH scavenging activity, total polyphenols, total flavonoids, tyrosinase inhibition activity (TIA) and collagenase inhibition activity (CIA ) was measured.
상기 DPPH는 안정화된 수용성 자유 라디칼로서 유기용매에서 안정한 화합물이며, 항산화 물질들은 자유 라디칼을 소거할 수 있어 있어 DPPH를 노란색으로 탈색시킨다. 따라서 DPPH의 보라색이 노란색으로 변하는 정도를 측정하여 시료의 항산화 효능을 평가할 수 있다.The DPPH is a stabilized water-soluble free radical and is a stable compound in an organic solvent, and antioxidants can scavenge free radicals, thereby decolorizing DPPH to yellow. Therefore, it is possible to evaluate the antioxidant efficacy of the sample by measuring the degree of changing the purple color of DPPH to yellow.
또한, 상기 Tyrosinase는 기질인 L-tyrosine을 3,4-dihydroxy-L-phenylananine(DOPA)로 합성하고, L-DOPA를 phenylanine-3,4-quinone으로 산화하여 최종적으로 멜라닌을 합성하는 효소로서, 피부색이나 색소 침착 여부를 좌우하는 데 주요한 역할을 하여 피부 미백에 있어서 tyrosinase를 저해하는 활성이 중요시 되고 있다.In addition, the Tyrosinase is an enzyme that synthesizes a substrate L-tyrosine to 3,4-dihydroxy-L-phenylananine (DOPA), oxidizes L-DOPA to phenylanine-3,4-quinone, and finally synthesizes melanin, It plays a major role in determining whether skin color or pigmentation occurs, and the activity of inhibiting tyrosinase in skin whitening is considered important.
또한, 상기 피부 진피조직 속에서는 collagen과 elastin이 그물망 구조를 형성하고 있으며 특히 collagen은 피부 전체 건조 중량의 약 70-80%를 차지하여 분해될 시에는 그물망 구조가 처지게 되고 피부의 탄력 감소 및 주름 생성의 원인이 된다. 따라서 주름 생성을 억제하기 위해서는 collagen의 분해와 손실을 최소화해야 하며, 피부의 주름개선 기능성 분석에 있어서도 collagen을 분해하는 효소인 collagenase를 저해하는 활성이 중요시 되고 있다.In addition, collagen and elastin form a network structure in the dermal tissue of the skin. In particular, collagen accounts for about 70-80% of the total dry weight of the skin, and when decomposed, the network structure sags, reducing skin elasticity and creating wrinkles cause of Therefore, in order to suppress the generation of wrinkles, it is necessary to minimize the degradation and loss of collagen, and in the functional analysis of skin wrinkle improvement, the activity of inhibiting collagenase, an enzyme that decomposes collagen, is important.
시험예 1. DPPH 라디칼 소거능(DSA), 총 폴리페놀 함량(TPC), 총 플라보노이드 함량(TFC) 측정Test Example 1. Measurement of DPPH radical scavenging activity (DSA), total polyphenol content (TPC), and total flavonoid content (TFC)
중심합성계획법(central composite design, CCD)을 이용하여 추출시간(X1), 추출온도(X2), 용매농도(X3)에 대하여, 5단계의 -1.68, -1, 0, 1 및 1.68로 코드화하여 실험범위를 설계하고, 설계된 하기 19가지 조건에 대하여 실험하여 실험값을 수득하였다.5 steps of -1.68, -1, 0, 1 and 1.68 for extraction time (X 1 ), extraction temperature (X 2 ), and solvent concentration (X 3 ) using central composite design (CCD) The experimental range was designed by coding with , and experimental values were obtained by testing the following 19 conditions.
1-1. DPPH 라디칼 소거능(%): 2,2-diphenyl-1- picrylhydrazyl(DPPH) 라디칼 소거 활성 측정을 통해 항산화능을 측정하였다. DPPH는 비교적 안정한 프리 라디칼로써 ascorbic acid, tocopherol등에 의해 환원되어 짙은 자색이 탈색되는 원리를 이용하여 항산화 활성을 간단히 측정할 수 있다. 시료를 희석하고 희석한 시료 0.25 mL와 0.1 M DPPH 1.25 mL를 혼합한 후 실온에서 20분간 암실 보관한 다음 517 nm에서 흡광도를 측정하였다. 대조군으로는 ascorbic acid(CAS 50-81-7, Sigma, USA)를 이용하였고, 시료와 동일한 조건으로 진행하였다. 라디칼 소거능은 하기 [수학식 6]에 따라 계산하였다.1-1. DPPH radical scavenging activity (%): The antioxidant activity was measured by measuring 2,2-diphenyl-1- picrylhydrazyl (DPPH) radical scavenging activity. As a relatively stable free radical, DPPH can be reduced by ascorbic acid, tocopherol, etc. and its antioxidant activity can be measured simply by using the principle that dark purple is discolored. After diluting the sample and mixing 0.25 mL of the diluted sample with 1.25 mL of 0.1 M DPPH, it was stored in the dark at room temperature for 20 minutes, and then absorbance was measured at 517 nm. Ascorbic acid (CAS 50-81-7, Sigma, USA) was used as a control, and the same conditions as the samples were used. The radical scavenging ability was calculated according to the following [Equation 6].
[수학식 6][Equation 6]
라디칼 소거활성(%)=[1-(시료의 흡광도/대조군의 흡광도)]X100Radical scavenging activity (%)=[1-(absorbance of sample / absorbance of control)]X100
1-2. 총 폴리페놀 함량(mg GAE/g DM): Folin-Denis 법을 변형하여 측정하였다. 각 조건에서 확보된 추출물 0.14 mL에 0.2 N Folin-Ciocalteu 용액 0.7 mL 첨가한 반응액을 실온에서 8분 동안 방치한 후 7.5% Na₂CO₃ 0.56 mL를 가하여 상온에서 1시간 동안 반응시켰다. 이후 분광광도계(Optizen 2120UV, KLab. Ltd., DaeJun, Korea)를 이용하여 765 nm에서 흡광도를 측정하였으며, galic acid(Sigma-Aldrich, Minneapolis, USA)를 표준물질로 사용하여 검량선을 작성하고 추출물의 TPC 함량을 mg galic acid equivalent (GAE)/g dry matter (DM)로 표시하였다.1-2. Total polyphenol content (mg GAE/g DM) : It was determined by modifying the Folin-Denis method. To 0.14 mL of the extract obtained under each condition, 0.7 mL of 0.2 N Folin-Ciocalteu solution was added, and the reaction solution was left at room temperature for 8 minutes, then 0.56 mL of 7.5% Na₂CO₃ was added and reacted at room temperature for 1 hour. Then, the absorbance was measured at 765 nm using a spectrophotometer (Optizen 2120UV, KLab. Ltd., DaeJun, Korea), and a calibration curve was prepared using galic acid (Sigma-Aldrich, Minneapolis, USA) as a standard material, and the The TPC content was expressed as mg gallic acid equivalent (GAE)/g dry matter (DM).
1-3. 총 플라보노이드 함량(mg QE/g DM): Zhishen 등의 방법을 변형하여 사용하였다. 플라보노이드에 알칼리를 작용시키면 황색으로 발색되는 원리에 근거하여 흡광도를 측정해 TFC 농도를 측정하였다. 각 시료 0.5 mL에 증류수 2.5 mL와 99.5%(v/v) 에탄올 1.5 mL 가한 후 1 M potassium acetate 0.1 mL와 10% aluminum chloride 0.1 mL를 가하여 교반한 후 실온에서 30분 동안 방치하였다. 415 nm에서 흡광도를 측정하였으며 quercetin (Sigma-Aldrich, Minneapolis, USA)을 25, 50, 100, 200 ug/mL로 희석하여 검량선을 구하여 플라보노이드 함량을 mg quercetin equivalent (QE)/g dry matter (DM)로 나타내었다. 1-3. Total flavonoid content (mg QE/g DM): A modified method of Zhishen et al. was used. TFC concentration was measured by measuring absorbance based on the principle that yellow color develops when alkali is applied to flavonoids. After adding 2.5 mL of distilled water and 1.5 mL of 99.5% (v/v) ethanol to 0.5 mL of each sample, 0.1 mL of 1 M potassium acetate and 0.1 mL of 10% aluminum chloride were added, stirred, and left at room temperature for 30 minutes. Absorbance was measured at 415 nm, and a calibration curve was obtained by diluting quercetin (Sigma-Aldrich, Minneapolis, USA) to 25, 50, 100, 200 ug/mL to determine the flavonoid content in mg quercetin equivalent (QE)/g dry matter (DM) indicated as
(min)extraction time
(min)
(℃)extraction temperature
(℃)
위 표 1에 나타낸 바와 같이, 총 폴리페놀 함량 및 DPPH 라디칼 소거능에 대한 실험값은 실시예 12에 따라 제조된 추출물이 다른 군에 비하여 우수한 것을 확인하였으며, 총 플라보노이드 함량에 대한 실험값은 실시예 7이 다른 군에 비하여 우수한 것을 확인하였다.As shown in Table 1 above, the experimental values for the total polyphenol content and DPPH radical scavenging ability confirmed that the extract prepared according to Example 12 was superior to that of other groups, and the experimental values for the total flavonoid content were different from Example 7 It was confirmed that it was superior to the group.
특히, 정제수(초음파)를 사용한 실시예 13, 열수 추출물인 비교예 1 및 에탄올 추출물인 비교예 2는 총 폴리페놀 함량, 총 플라보노이드 함량 및 DPPH 라디칼 소거능 모두 수치가 낮은 것을 확인하였다. In particular, in Example 13 using purified water (ultrasound), Comparative Example 1 as a hot water extract, and Comparative Example 2 as an ethanol extract, it was confirmed that the total polyphenol content, the total flavonoid content and the DPPH radical scavenging ability were all low.
시험예 2. 티로시나제(Tyrosinase) 억제 효과 및 콜라게나제(Collagenase) 억제Test Example 2. Tyrosinase (Tyrosinase) inhibitory effect and collagenase (Collagenase) inhibition 효과 측정Effect measurement
중심합성계획법(central composite design, CCD)을 이용하여 추출시간(X1), 추출온도(X2), 용매농도(X3)에 대하여, 5단계의 -1.68, -1, 0, 1 및 1.68로 코드화하여 실험범위를 설계하고, 설계된 하기 19가지 조건에 대하여 실험하여 실험값을 수득하였다.5 steps of -1.68, -1, 0, 1 and 1.68 for extraction time (X 1 ), extraction temperature (X 2 ), and solvent concentration (X 3 ) using central composite design (CCD) The experimental range was designed by coding with , and experimental values were obtained by testing the following 19 conditions.
2-1. 티로시나제 저해능(%): Tyrosinase는 피부의 표피 기저층에서 tyrosine을 산화시켜 멜라닌의 생성을 촉진시키는 효소로서 피부 미백과 노화 방지를 위해서는 tyrosinase의 활성 억제가 요구된다. 실험을 위해 sodium phosphate monobasic anhydrous와 sodium phosphate dibasic anhydrous을 이용하여 PH 6.8의 7 mM sodium phosphate buffer를 제조하였고, 시료 0.2 ml와 3,4-dihydroxy phenylanin(I-dopa) 2 mg/ml에 mushroom tyrosinase(125 unit)를 가하여 25 ℃에서 30분 동안 반응하였다. 반응 후에는 dopa chrome를 475 ㎚파장에서 흡광도를 측정하였다. 양성 대조군으로는 kojic acid를 사용하였다. Tyrosinase의 저해 활성은 하기 [수학식 7]에 따라 계산하였다.2-1. Tyrosinase inhibitory ability (%): Tyrosinase is an enzyme that promotes the production of melanin by oxidizing tyrosine in the basal layer of the epidermis. For the experiment, 7 mM sodium phosphate buffer at pH 6.8 was prepared using sodium phosphate monobasic anhydrous and sodium phosphate dibasic anhydrous, and mushroom tyrosinase ( 125 unit) was added and reacted at 25 °C for 30 minutes. After the reaction, absorbance of dopa chrome was measured at a wavelength of 475 nm. As a positive control, kojic acid was used. Tyrosinase inhibitory activity was calculated according to the following [Equation 7].
[수학식 7][Equation 7]
저해활성(%)=[1-(시료의 흡광도/대조군의 흡광도)]X100Inhibitory activity (%)=[1-(absorbance of sample / absorbance of control)]X100
2-2. 콜라게나제 저해능(%): Collagenase는 체내 collagen을 분해하여 주름생성과 탄력저하를 일으키는 효소로서 피부 노화의 원인이 되는 주름 생성을 억제하기 위해서는 collagenase의 저해가 요구된다. 실험에 필요한 buffer는 1 M Tris(hydroxylmetyl)Aminomethane와 4 mM CaCl2(Calcium chloride), 1 M HCl을 이용하여 pH 7.5로 제조하였고 buffer로 4-phenyl azobenzyloxycarbonyl-pro-leu-gly-pro-d-arg와 collagenase를 제조하였다. 이어서 시료 0.05 mL에 4-phenyl azobenzyloxycarbonyl-pro-leu-gly-pro-d-arg 1.2 mg/ml를 첨가한 후 collagenase와 혼합하여 water bath에서 37 ℃로 30분간 반응시켰다. 반응 후에는 20% citric acid 0.25 mL을 넣어 collagenase 반응을 정지시킨 후, ethyl acetate 1.2 mL을 첨가하여 shaker에 10분간 교반하였다. 교반 후에는 상등액만 320 nm 파장에서 흡광도를 측정하였다. 양성 대조군으로는 ascorbic acid를 이용하였다. Collagenase 저해 활성은 하기 [수학식 8]에 따라 계산하였다.2-2. Collagenase inhibitory ability (%): Collagenase is an enzyme that decomposes collagen in the body to cause wrinkle formation and loss of elasticity. The buffer required for the experiment was prepared at pH 7.5 using 1 M Tris(hydroxylmetyl)Aminomethane, 4 mM CaCl 2 (Calcium chloride), and 1 M HCl, and 4-phenyl azobenzyloxycarbonyl-pro-leu-gly-pro-d- arg and collagenase were prepared. Then, 1.2 mg/ml of 4-phenyl azobenzyloxycarbonyl-pro-leu-gly-pro-d-arg was added to 0.05 mL of the sample, mixed with collagenase, and reacted in a water bath at 37 °C for 30 minutes. After the reaction, 0.25 mL of 20% citric acid was added to stop the collagenase reaction, 1.2 mL of ethyl acetate was added, and the mixture was stirred on a shaker for 10 minutes. After stirring, only the supernatant was measured for absorbance at a wavelength of 320 nm. Ascorbic acid was used as a positive control. Collagenase inhibitory activity was calculated according to the following [Equation 8].
[수학식 8][Equation 8]
저해활성(%)=[1-(시료의 흡광도/대조군의 흡광도)]X100Inhibitory activity (%)=[1-(absorbance of sample / absorbance of control)]X100
(min)extraction time
(min)
(℃)extraction temperature
(℃)
위 표 2에 나타낸 바와 같이, 티로시나제 저해능 및 콜라게나제 저해능에 대한 실험값은 모두 실시예 14가 다른 군에 비하여 우수한 것을 확인하였다.As shown in Table 2 above, the experimental values for the tyrosinase inhibitory ability and the collagenase inhibitory ability confirmed that Example 14 was superior to the other groups.
특히, 정제수(초음파)를 사용한 실시예 13, 열수 추출물인 비교예 1 및 에탄올 추출물인 비교예 2는 티로시나제 저해능 및 콜라게나제 저해능 모두 수치가 낮은 것을 확인하였다. In particular, it was confirmed that Example 13 using purified water (ultrasound), Comparative Example 1, which is a hot water extract, and Comparative Example 2, which is an ethanol extract, both tyrosinase inhibitory ability and collagenase inhibitory ability were low.
상기 [표 1] 및 [표 2]에 나타낸 실험값을 살펴보면, 총 폴리페놀 함량, 총 플라보노이드 함량, DPPH 라디칼 소거능, 티로시나제 저해능 및 콜라게나제 저해능이 모두 고르게 우수한 군은 실시예 12인 것을 확인하였다.Looking at the experimental values shown in [Table 1] and [Table 2], it was confirmed that Example 12 was the group that was equally excellent in total polyphenol content, total flavonoid content, DPPH radical scavenging ability, tyrosinase inhibitory ability and collagenase inhibitory ability.
상기 실험값들을 기반으로 Design Expert software(V.8.0, State-Ease, Inc, Minneapolis, USA)를 사용하여 최적조건을 예측하기 위하여 상기 [수학식 1] 내지 [수학식 5]와 같은 회귀식을 도출하였다.Based on the experimental values, a regression equation such as [Equation 1] to [Equation 5] is derived to predict the optimal condition using Design Expert software (V.8.0, State-Ease, Inc, Minneapolis, USA) did
시험예 3. 최적 조건 탐색Test Example 3. Search for optimal conditions
YTPC=+11.87710-0.27813X1+0.062526X2-0.10999X3-0.038357X1 2+0.011033X1X2-8.04762E-004X2 2+9.16875E-003X1X3-2.72059E-004X2X3-9.82967E-004X3 2 [Equation 1]
Y TPC =+11.87710-0.27813X 1 +0.062526X 2 -0.10999X 3 -0.038357X 1 2 +0.011033X 1 X 2 -8.04762E-004X 2 2 +9.16875E-003X 1 X 3 -2.72059E-004X 2 X 3 -9.82967E-004X 3 2
YTFC=+0.29505-0.027059X1-3.97311E-003X2+2.06369E-003X3+6.56102E-004X1 2+2.35575E-004X1X2+1.4523E-005X2 2-5.60826E-005X1X3+4.47917E-005X2X3-9.59741E-006X3 2 [Equation 2]
Y TFC =+0.29505-0.027059X 1 -3.97311E-003X 2 +2.06369E-003X 3 +6.56102E-004X 1 2 +2.35575E-004X 1 X 2 +1.4523E-005X 2 2 -5.60826E-005X 1 X 3 +4.47917E-005X 2 X 3 -9.59741E-006X 3 2
YDPPH=-12.01377-0.23738X1+1.10578X2+1.88331X3-0.18487X1 2+0.065359X1X2-0.015823X2 2+0.018519X1X3+6.53596E-003X2X3-0.027340X3 2 [Equation 3]
Y DPPH =-12.01377-0.23738X 1 +1.10578X 2 +1.88331X 3 -0.18487X 1 2 +0.065359X 1 X 2 -0.015823X 2 2 +0.018519X 1 X 3 +6.53596E-003X 2 X 3 -0.027340X 3 2
YTI=+21.89570+2.31910X1+0.73168X2+0.89582X3-0.10956X1 2+6.37868E-003X1X2-7.16647E-003X2 2-1.71875E-003X1X3+2.17402E-003X2X3-7.54092EX3 2 [Equation 4]
Y TI =+21.89570+2.31910X 1 +0.73168X 2 +0.89582X 3 -0.10956X 1 2 +6.37868E-003X 1 X 2 -7.16647E-003X 2 2 -1.71875E-003X 1 X 3 +2.17402E-003X 2 X 3 -7.54092EX 3 2
YCI=7.18898+0.47210X1+1.74516X2+1.05430X3-0.20030X1 2+0.036374X1X2-0.013524X2 2+0.042529X1X3-7.41903E-003X2X3-8.53821E-003X3 2 [Equation 5]
Y CI =7.18898+0.47210X 1 +1.74516X 2 +1.05430X 3 -0.20030X 1 2 +0.036374X 1 X 2 -0.013524X 2 2 +0.042529X 1 X 3 -7.41903E-003X 2 X 3 -8.53821E- 003X 3 2
3-1. 총 폴리페놀 함량(TPC)에 미치는 조건 탐색3-1. Exploring conditions affecting total polyphenol content (TPC)
반응표면 분석법 중 하나인 중심합성계획법(central composite design, CCD)을 이용하여 도출된 조건에 따라 측정된 총 폴리페놀 함량(TPC)에 대한 실험값은 [표 1]에 나타냈다. CCD에 의해 도출된 19개의 조건 중 최대 총 폴리페놀 함량(TPC)은 실시예 12였다.The experimental values for the total polyphenol content (TPC) measured according to the conditions derived using the central composite design (CCD), one of the response surface analysis methods, are shown in [Table 1]. The maximum total polyphenol content (TPC) of 19 conditions derived by CCD was Example 12.
항산화 활성은 측정값으로부터 얻어진 값을 기반으로 분산분석(Analysis of variance, ANOVA)을 통하여 결과의 유의성을 평가하였을 때, R 2 값은 0.8341이며 p 값은 0.0430으로 유의성이 인정되어 회귀함수가 적합한 모델임을 확인하였다. When the significance of antioxidant activity was evaluated through analysis of variance (ANOVA) based on the value obtained from the measured value, the R 2 value was 0.8341 and the p value was 0.0430, which was significant, so the regression function was suitable model. It was confirmed that
도 1은 추출 시간, 추출 온도와 에탄올 농도 중 두 개의 독립변수를 중간값에 고정한 상태로 한 가지 독립변수의 변동에 따른 총 폴리페놀 함량(TPC)의 증감을 확인한 일변수 곡선으로서, 독립 변수들이 TPC에 미치는 영향을 확인한 결과 TPC 함량은 에탄올 농도와 온도의 변화에 큰 영향을 받았으며, 추출시간은 TPC 함량에 큰 영향에 없는 것을 확인할 수 있었다.1 is a univariate curve confirming the increase or decrease of total polyphenol content (TPC) according to the change of one independent variable with two independent variables of extraction time, extraction temperature and ethanol concentration fixed at the median value. As a result of confirming the effect on TPC, it was confirmed that the TPC content was greatly affected by changes in ethanol concentration and temperature, and the extraction time had no significant effect on the TPC content.
독립 변수들의 상호작용에 의한 교호효과를 분석하기 위하여 두 개의 독립 변수를 동시에 변화시키고 나머지 한 개의 변수를 중간값에 고정하여 실험범위 내에서 TPC 함량의 변화를 3차원 반응표면곡선으로 시각화하였다. In order to analyze the interaction effect due to the interaction of the independent variables, the change in the TPC content within the experimental range was visualized as a three-dimensional response surface curve by changing two independent variables at the same time and fixing the other variable to the median value.
도 2에 도시된 바와 같이, 추출시간 증가에 따라 TPC 함량이 증가하다가 점차 감소하는 경향이 공통적으로 확인되었으며, 에탄올 농도가 증가할수록 TPC 함량이 급격하게 감소하는 경향을 확인할 수 있었다. 또한 도 2a와 2c에서 추출온도가 증가할수록 TPC 함량이 증가하는 경향을 보였는데 에탄올 농도에 비해서 TPC 함량에 미치는 영향은 미미한 것으로 나타났다. As shown in FIG. 2 , it was confirmed that the TPC content increased and then gradually decreased as the extraction time increased, and it was confirmed that the TPC content rapidly decreased as the ethanol concentration increased. In addition, in FIGS. 2a and 2c , as the extraction temperature increased, the TPC content showed a tendency to increase, but the effect on the TPC content was insignificant compared to the ethanol concentration.
3-2. 총 플라보노이드 함량(TFC)에 미치는 조건 탐색3-2. Exploring conditions affecting total flavonoid content (TFC)
반응표면 분석법 중 하나인 중심합성계획법(central composite design, CCD)을 이용하여 도출된 조건에 따라 측정된 총 플라보노이드 함량(TFC)에 대한 실험값은 [표 1]에 나타냈다. CCD에 의해 도출된 19개의 조건 중 최대 총 플라보노이드 함량(TFC)은 실시예 7이였다.Experimental values for total flavonoid content (TFC) measured according to conditions derived using central composite design (CCD), one of the response surface analysis methods, are shown in [Table 1]. The maximum total flavonoid content (TFC) among 19 conditions derived by CCD was Example 7.
항산화 활성은 측정값으로부터 얻어진 값을 기반으로 분산분석(Analysis of variance, ANOVA)을 통하여 결과의 유의성을 평가하였을 때, R 2 값은 0.9017이며 p 값은 0.0084로 유의성이 인정되어 회귀함수가 적합한 모델임을 확인하였다. 독립 변수인 추출온도(p = 0.0083)와 에탄올 농도(p = 0.0003) 또한 유의성이 높다는 것이 확인된 반면, 추출시간(p = 0.5071)은 다른 조건들에 비하여 유의성이 낮은 것으로 판정되었다. 이를 통하여 다른 조건들에 비하여 에탄올 농도가 TFC 수율에 있어 주요한 변수임을 확인할 수 있었다.When the significance of antioxidant activity was evaluated through Analysis of variance (ANOVA) based on the value obtained from the measured value, the R 2 value was 0.9017 and the p value was 0.0084, which was significant, so the regression function was suitable. It was confirmed that The independent variables, extraction temperature ( p = 0.0083) and ethanol concentration ( p = 0.0003) were also confirmed to have high significance, whereas extraction time ( p = 0.5071) was determined to have low significance compared to other conditions. Through this, it was confirmed that the ethanol concentration was a major variable in the TFC yield compared to other conditions.
도 3은 추출 시간, 추출 온도와 에탄올 농도 중 두 개의 독립변수를 중간값에 고정한 상태로 한 가지 독립변수의 변동에 따른 총 플라보노이드 함량(TFC)의 증감을 확인한 일변수 곡선으로서, TFC 수율은 에탄올 농도에 큰 영향을 받는다는 것을 확인할 수 있었다. 3 is a univariate curve confirming the increase or decrease of total flavonoid content (TFC) according to the change of one independent variable with two independent variables of extraction time, extraction temperature and ethanol concentration fixed at the median value. TFC yield is ethanol It was confirmed that the concentration was greatly affected.
TFC 수율에 영향을 주는 두 개의 독립 변수들의 상호관계를 3차원 그래프에 도식화한 결과, 도 4a와 4b에 나타난 바와 같이 추출시간은 TFC에 유의한 영향이 없음을 알 수 있으며, 도 4a와 4c에 보는 바와 같이 추출온도가 높아질수록 TFC 수율이 점차 증가하는 경향을 확인할 수 있었다. 에탄올 농도가 TFC 수율에 미치는 영향을 도 4b와 4c에 시각화했는데 농도가 증가함에 따라 TFC가 비례하여 증가하는 것을 확인할 수 있었다.As a result of schematizing the interrelationship of two independent variables affecting the TFC yield in a three-dimensional graph, it can be seen that the extraction time has no significant effect on TFC as shown in FIGS. 4a and 4b, and in FIGS. 4a and 4c As can be seen, it was confirmed that the TFC yield gradually increased as the extraction temperature increased. The effect of the ethanol concentration on the TFC yield was visualized in FIGS. 4b and 4c, and it was confirmed that the TFC increased proportionally as the concentration increased.
페놀성 화합물은 지용성과 수용성의 화합물들로 구분이 되어 추출용매에 따라 추출되는 성분들이 달라지는 것으로 알려져 있다. 이러한 결과들로 보아 본 발명의 지충이는 지용성 화합물의 함량이 높아 에탄올 농도가 높아질수록 플라보노이드의 수율이 증가한 것으로 보인다.Phenolic compounds are classified into fat-soluble and water-soluble compounds, and it is known that the extracted components vary depending on the extraction solvent. Judging from these results, it seems that the yield of flavonoids increases as the ethanol concentration increases due to the high content of lipid-soluble compounds in the lichen of the present invention.
3-3. DPPH 라디칼 소거능(DSA)에 미치는 조건 탐색3-3. Exploration of conditions affecting DPPH radical scavenging capacity (DSA)
반응표면 분석법 중 하나인 중심합성계획법(central composite design, CCD)을 이용하여 도출된 조건에 따라 측정된 DPPH 라디칼 소거능(DSA)에 대한 실험값은 [표 1]에 나타냈다. CCD에 의해 도출된 19개의 조건 중 최대 DPPH 라디칼 소거능(DSA)은 실시예 12였다.Experimental values for DPPH radical scavenging ability (DSA) measured according to conditions derived using central composite design (CCD), one of the response surface analysis methods, are shown in [Table 1]. The maximum DPPH radical scavenging capacity (DSA) among 19 conditions derived by CCD was Example 12.
항산화 활성은 측정값으로부터 얻어진 값을 기반으로 분산분석(Analysis of variance, ANOVA)을 통하여 결과의 유의성을 평가하였을 때, R 2 값은 0.8557이며 p 값은 0.0307로 유의성이 인정되어 회귀함수가 적합한 모델임을 확인하였다. 각 독립 변수의 유의성 평가에 있어 추출온도(p = 0.0463) > 에탄올 농도(p = 0.0757) > 추출시간(p = 0.7073) 순으로 영향을 받는 것을 확인됨으로써 지충이 추출물의 RSA는 온도에 대한 영향을 가장 크게 받는다는 것을 확인 할 수 있었다.When the significance of antioxidant activity was evaluated through analysis of variance (ANOVA) based on the value obtained from the measured value, the R 2 value was 0.8557 and the p value was 0.0307, which was significant, so the regression function was suitable model. It was confirmed that In evaluating the significance of each independent variable, it was confirmed that the extraction temperature ( p = 0.0463) > ethanol concentration ( p = 0.0757) > extraction time ( p = 0.7073) was affected in the order, so the RSA of the extract I was able to confirm that I received the largest amount.
도 5는 추출 시간, 추출 온도와 에탄올 농도 중 두 개의 독립변수를 중간값에 고정한 상태로 한 가지 독립변수의 변동에 따른 DSA의 증감을 확인한 일변수 곡선으로서, 추출온도가 DSA에 가장 큰 영향을 미친다는 것이 확인되었다. 두 독립 변수간의 상호관계를 확인하기 위해 추출시간, 추출온도와 에탄올 농도 중 두 개의 독립 변수를 변화시켜 DSA에 미치는 영향을 반응표면곡선으로 시각화(도 6)한 결과, 이는 앞선 일변수곡선(도 5)과 비슷한 경향을 보여주며, 도 6의 추출시간과 추출온도에 대한 상관관계를 나타낸 도 6a에서 DSA는 추출시간이 증가할수록 증가하다가 12~15분 부근에서 부터 점차 낮아지는 것을 확인할 수 있었고, 추출온도의 증가에 따라 수율이 증가하다가 70~80 ℃ 부근에서 추출시간과 같이 점차 낮아지는 비슷한 경향을 보였다. 5 is a univariate curve confirming the increase or decrease of DSA according to the change of one independent variable with two independent variables of extraction time, extraction temperature, and ethanol concentration fixed at the median value. The extraction temperature has the greatest effect on DSA. It has been confirmed that crazy In order to confirm the correlation between the two independent variables, the effect on DSA by changing two independent variables among extraction time, extraction temperature, and ethanol concentration was visualized as a response surface curve (FIG. 6), which was 5), and in FIG. 6a showing the correlation between extraction time and extraction temperature in FIG. 6, it was confirmed that DSA increased as the extraction time increased, and then gradually decreased from around 12 to 15 minutes, The yield increased with the increase of the extraction temperature, but showed a similar tendency to decrease gradually as the extraction time was around 70~80 ℃.
또한 도 6b와 6c에 나타낸 바와 같이, 에탄올 농도가 증가함에 따라 수율도 비례하여 증가하다가 50 부피%에서부터 급격히 감소하는 것을 확인할 수 있었다. In addition, as shown in FIGS. 6b and 6c, as the ethanol concentration increased, the yield also increased proportionally, and then it was confirmed that the yield decreased sharply from 50% by volume.
3-4. 티로시나제 억제능에 미치는 조건 탐색3-4. Exploring conditions affecting tyrosinase inhibitory ability
반응표면 분석법 중 하나인 중심합성계획법(central composite design, CCD)을 이용하여 도출된 조건에 따라 측정된 티로시나제 억제능(TIA)에 대한 실험값은 [표 2]에 나타냈다. CCD에 의해 도출된 19개의 조건 중 최대 티로시나제 억제능은 실시예 14였다.Experimental values for tyrosinase inhibitory ability (TIA) measured according to conditions derived using central composite design (CCD), one of the response surface analysis methods, are shown in [Table 2]. The maximum tyrosinase inhibitory ability among 19 conditions induced by CCD was Example 14.
본 모델의 유의성은 분산분석(ANOVA)을 통해 검증되었으며, 분산분석(ANOVA)에 따르면 회귀식의 적합도를 측정하는 척도인 결정계수인 R 2 은 0.8548이며 p 값이 0.0287로 유의성이 인정되어 회귀함수가 적합한 모델임을 확인하였다.The significance of this model was verified through analysis of variance (ANOVA), and according to analysis of variance (ANOVA), the coefficient of determination, R2 , which is a measure of the fitness of the regression equation, was 0.8548, and the p value was 0.0287, which was recognized as significant. was confirmed to be a suitable model.
도 7은 추출 시간, 추출 온도와 에탄올 농도 중 두 개의 독립변수를 중간값에 고정한 상태로 한 가지 독립변수의 변동에 따른 티로시나제 억제능(TIA)의 증감을 확인한 일변수 곡선을 나타내었다. 이때 한 가지의 독립변수를 제외한 두 가지의 독립변수는 중간값인 code 0에 고정하였다. 7 shows a univariate curve confirming the increase or decrease of tyrosinase inhibitory ability (TIA) according to the change of one independent variable with two independent variables of extraction time, extraction temperature, and ethanol concentration fixed at the median value. At this time, except for one independent variable, two independent variables were fixed at the median value of
도 7에 따르면, 추출 시간, 추출 온도와 에탄올 농도 중 두 개의 독립변수를 중간값에 고정한 상태로 한 가지 독립변수의 변동에 따른 TIA의 증감을 확인한 일변수 곡선으로서, 에탄올 농도가 TIA에 가장 큰 영향을 미친다는 것이 확인되었다. 두 독립 변수간의 상호관계를 확인하기 위해 추출시간, 추출온도와 에탄올 농도 중 두 개의 독립 변수를 변화시켜 TIA에 미치는 영향을 반응표면곡선으로 시각화(도 8)한 결과, 이는 앞선 일변수곡선(도 7)과 비슷한 경향을 보여주며, 도 8의 추출시간과 추출온도에 대한 상관관계를 나타낸 도 8a에서 TIA는 추출시간이 증가할수록 증가하다가 12~15 분 부근에서 부터 점차 낮아지는 것을 확인할 수 있었고, 추출온도의 증가에 따라 수율이 증가하다가 70~80 ℃ 부근에서 추출시간과 같이 점차 낮아지는 비슷한 경향을 보였다. According to FIG. 7, it is a univariate curve confirming the increase or decrease of TIA according to the change of one independent variable with two independent variables of extraction time, extraction temperature, and ethanol concentration fixed at the median value. has been confirmed to have an effect. In order to check the correlation between the two independent variables, the effect on TIA by changing two independent variables among extraction time, extraction temperature and ethanol concentration was visualized as a response surface curve (FIG. 8). As a result, the previous univariate curve (FIG. 7), and in FIG. 8a showing the correlation between the extraction time and the extraction temperature in FIG. 8, it was confirmed that the TIA increased as the extraction time increased, and then gradually decreased from around 12 to 15 minutes, The yield increased with the increase of the extraction temperature, but showed a similar tendency to decrease gradually as the extraction time was around 70~80 ℃.
또한 도 8b와 8c에 나타낸 바와 같이, 에탄올 농도가 증가함에 따라 수율도 비례하여 증가하다가 50 부피%에서부터 급격히 감소하는 것을 확인할 수 있었다. In addition, as shown in FIGS. 8b and 8c , it was confirmed that the yield also increased proportionally as the ethanol concentration increased, and then rapidly decreased from 50% by volume.
2-3. 콜라게나제 억제능에 미치는 조건 탐색2-3. Exploration of conditions affecting collagenase inhibitory ability
반응표면 분석법 중 하나인 중심합성계획법(central composite design, CCD)을 이용하여 도출된 조건에 따라 측정된 콜라게나제 억제능(CIA)에 대한 실험값은 [표 2]에 나타냈다. CCD에 의해 도출된 19개의 조건 중 최대 콜라게나제 억제능은 실시예 14였다.Experimental values for collagenase inhibitory ability (CIA) measured according to conditions derived using central composite design (CCD), one of the response surface analysis methods, are shown in [Table 2]. The maximum collagenase inhibitory ability among 19 conditions induced by CCD was Example 14.
본 모델의 유의성은 분산분석(ANOVA)을 통해 검증되었으며, 분산분석(ANOVA)에 따르면 회귀식의 적합도를 측정하는 척도인 결정계수인 R 2 은 0.9252이며 p 값이 0.0035으로 유의성이 인정되어 회귀함수가 적합한 모델임을 확인하였다.The significance of this model was verified through analysis of variance (ANOVA), and according to analysis of variance (ANOVA), the coefficient of determination, R 2 , which is a measure of the fit of the regression equation, was 0.9252, and the p value was 0.0035, which was recognized as significant. was confirmed to be a suitable model.
도 9는 추출 시간, 추출 온도와 에탄올 농도 중 두 개의 독립변수를 중간값에 고정한 상태로 한 가지 독립변수의 변동에 따른 DSA의 증감을 확인한 일변수 곡선으로서, 두 가지의 독립변수를 중간값인 0에 고정한 상태로 한 가지의 독립변수가 CAI에 미치는 영향을 나타내었다. 9 is a univariate curve confirming the increase or decrease of DSA according to the change of one independent variable with two independent variables of extraction time, extraction temperature, and ethanol concentration fixed at the median value. The effect of one independent variable on CAI was shown while fixed at 0.
도 9에 따르면, 추출 시간, 추출 온도와 에탄올 농도 중 두 개의 독립변수를 중간값에 고정한 상태로 한 가지 독립변수의 변동에 따른 CIA의 증감을 확인한 일변수 곡선으로서, 에탄올 농도가 CIA에 가장 큰 영향을 미친다는 것이 확인되었다. 두 독립 변수간의 상호관계를 확인하기 위해 추출시간, 추출온도와 에탄올 농도 중 두 개의 독립 변수를 변화시켜 CIA에 미치는 영향을 반응표면곡선으로 시각화(도 10)한 결과, 이는 앞선 일변수곡선(도 9)과 비슷한 경향을 보여주며, 도 10의 추출시간과 추출온도에 대한 상관관계를 나타낸 도 10a에서 TIA는 추출시간이 증가할수록 증가하다가 12~15 분 부근에서 부터 점차 낮아지는 것을 확인할 수 있었고, 추출온도의 증가에 따라 수율이 증가하다가 70~80 ℃ 부근에서 추출시간과 같이 점차 낮아지는 비슷한 경향을 보였다. According to FIG. 9, it is a univariate curve confirming the increase or decrease of CIA according to the change of one independent variable with two independent variables of extraction time, extraction temperature, and ethanol concentration fixed at the median value. has been confirmed to have an effect. In order to confirm the correlation between the two independent variables, the effect on CIA by changing two independent variables among extraction time, extraction temperature, and ethanol concentration was visualized as a response surface curve (Fig. 10). 9), and in FIG. 10a showing the correlation between extraction time and extraction temperature in FIG. 10, it was confirmed that TIA increased as the extraction time increased, and then gradually decreased from around 12 to 15 minutes, The yield increased with the increase of the extraction temperature, but showed a similar tendency to decrease gradually as the extraction time was around 70~80 ℃.
또한 도 10b와 10c에 나타낸 바와 같이, 에탄올 농도가 증가함에 따라 수율도 비례하여 증가하다가 50 부피%에서부터 급격히 감소하는 것을 확인할 수 있었다. In addition, as shown in FIGS. 10b and 10c , as the ethanol concentration increased, the yield also increased proportionally, and then it was confirmed that the yield decreased sharply from 50% by volume.
2-4. 최적조건 탐색2-4. Optimal condition search
지충이 초음파 추출에 있어 주요 3 조건인 항산화, TIA, CIA의 개별 최적화 결과를 바탕으로 Design Expert를 이용하여 반응표면곡선을 겹치기기법(superimposing)으로 3개 변수의 공통 최적화 조건을 예측하여 도 11(X1: 추출시간, X2: 추출온도)에 나타내었다. 11( X 1 : extraction time, X 2 : extraction temperature).
이때 독립변수 중 에탄올 농도를 고정한 채로 DSA, TPC, TFC, TAI, CAI의 저해 활성 최적점을 확보하는 한편, 추출 공정 중의 비용을 최소화하여 경제성을 확보하고자 추출 시간과 추출 온도의 값이 가장 낮은 지점을 최적점으로 선정하였다. 이때 지충이 초음파 추출의 최적 추출 조건은 50.0 부피%의 에탄올 농도에서 81.5 ℃온도로 11.0분 동안 추출한 것으로 예측되었고, 이때 종속변수인 DPPH 라디칼 소거능은 90.09%, 총 폴리페놀 함량은 12.02 mg GAE/g DM, 총 플라보노이드 함량은 0.22 mg QE/g DM, 티로시나제 억제능은 87.85% 및 콜라게나제 억제능 91.78%로 나타났다.At this time, the point where the extraction time and extraction temperature are the lowest in order to secure the optimal point of inhibitory activity of DSA, TPC, TFC, TAI, and CAI while fixing the ethanol concentration among the independent variables, while minimizing the cost during the extraction process to secure economic feasibility was selected as the optimal point. At this time, it was predicted that the optimal extraction conditions for ultrasonic extraction of worms were extracted at an ethanol concentration of 50.0% by volume at a temperature of 81.5°C for 11.0 minutes, and the dependent variable DPPH radical scavenging ability was 90.09%, and the total polyphenol content was 12.02 mg GAE/g. DM, total flavonoid content was 0.22 mg QE/g DM, tyrosinase inhibitory activity was 87.85%, and collagenase inhibitory activity was 91.78%.
상기 최적 조건에서 검증 실험을 수행 한 결과, DPPH 라디칼 소거능은 90.08%, 총 폴리페놀 함량은 13.27 mg GAE/g DM, 총 플라보노이드 함량은 0.30 mg QE/g DM, 티로시나제 억제능은 87.94% 및 콜라게나제 억제능 91.79%로 나타나 예측값과 유사한 값을 보이므로 통계기반 최적화를 사용하여 예측의 신뢰성을 확인했다.As a result of performing the verification experiment under the optimal conditions, the DPPH radical scavenging ability was 90.08%, the total polyphenol content was 13.27 mg GAE/g DM, the total flavonoid content was 0.30 mg QE/g DM, and the tyrosinase inhibitory ability was 87.94% and collagenase Since the inhibitory ability was found to be 91.79%, similar to the predicted value, the reliability of the prediction was confirmed using statistical-based optimization.
시험예 3. 지표물질 확인Test Example 3. Identification of indicator substances
도 12는 본 발명의 실시예 12에 따라 제조된 지충이 초음파 추출물의 지표물질을 HPLC로 측정한 NMR데이터이다.12 is NMR data obtained by measuring the indicator material of the ultrasonic extract of worms prepared according to Example 12 of the present invention by HPLC.
도 12에 도시된 바와 같이, 본 발명 지충이 초음파 추출물의 지표물질은 노빌레틴(nobiletin, peak No. 10, elution time: 7.49 min, m/z: 403.11)인 것을 확인하였다.As shown in FIG. 12 , it was confirmed that the indicator material of the ultrasonic extract of the present invention is nobiletin (nobiletin, peak No. 10, elution time: 7.49 min, m/z: 403.11).
시험예 4. TRP-1, MMP-1과 MMP-9의 발현 저해효과 확인 Test Example 4. Confirmation of the expression inhibitory effect of TRP-1, MMP-1 and MMP-9
본 발명의 실시예 12에 따라 제조된 지충이 초음파 추출물에 대한 TRP-1, MMP-1과 MMP-9의 발현 저해효과는 reverse transcription-polymerase chain reaction (RT-PCR) 방법으로 확인하였다. 먼저, B16F0 세포를 24-well plate에 1x106 cell/well로 접종한 후 0.25, 0.5, 1.0, 2.0 ㎍/mL 농도의 지충이 초음파 추출물을 24시간 동안 처리하였다. 배양된 세포주로부터 RNA의 추출은 AccuPrep® Universal RNA Extraction kit(Bioneer, Daejeon, Korea)를 이용하였고 분리된 RNA로부터 cDNA를 합성하였다. 확보된 cDNA를 주형으로 TRP-1, MMP-1과 MMP-9의 유전자를 증폭하였고, internal control로 β-actin 유전자를 확인하였다. 이때 사용된 프라이머 서열(primer sequence)은 하기 [표 4] 나타내었다. The inhibitory effect on the expression of TRP-1, MMP-1 and MMP-9 on the ultrasonic extract prepared according to Example 12 of the present invention was confirmed by the reverse transcription-polymerase chain reaction (RT-PCR) method. First, B16F0 cells were inoculated in a 24-well plate at 1x10 6 cells/well, and then treated with 0.25, 0.5, 1.0, and 2.0 μg/mL concentrations of Ultrasonic worm extract for 24 hours. RNA was extracted from the cultured cell line using AccuPrep® Universal RNA Extraction kit (Bioneer, Daejeon, Korea), and cDNA was synthesized from the isolated RNA. The genes of TRP-1, MMP-1 and MMP-9 were amplified using the obtained cDNA as a template, and the β-actin gene was confirmed as an internal control. The primer sequences used at this time are shown in [Table 4] below.
증폭 과정은 TRP-1의 경우 95.0 ℃, 5분(초기변성)으로 시작하여 95.0 ℃, 5초(변성반응); 60.0 ℃, 31초(결합반응); 72.0 ℃, 30초(연장반응)로 구성된 증폭과정을 25회 실시하였다. 결합반응 온도는 MMP-1, MMP-9과 β-actin에서 각각 55.0 ℃, 59 ℃와 60.4 ℃로 진행하였으며 각각의 PCR 생성물은 gel red를 포함한 1.2% agarose gel에 전기영동한 후 Gel DocTM XR+ System과 Quantity One software(Bio-Rad, Hercules, CA, USA)로 발색강도를 측정하여 비교하였다.In the case of TRP-1, the amplification process starts at 95.0 °C, 5 minutes (initial denaturation), at 95.0 °C, 5 seconds (denaturation reaction); 60.0 °C, 31 sec (binding reaction); The amplification process consisting of 72.0 °C and 30 seconds (extended reaction) was performed 25 times. The binding reaction temperature was 55.0 ℃, 59 ℃, and 60.4 ℃ for MMP-1, MMP-9 and β-actin, respectively, and each PCR product was electrophoresed on 1.2% agarose gel including gel red, followed by Gel DocTM XR+ System and Quantity One software (Bio-Rad, Hercules, CA, USA) measured and compared the color development intensity.
도 13a는 본 발명의 실시예 12에 따라 제조된 지충이 초음파 추출물을 이용하여 멜라닌 생성과 콜라겐 분해의 주요효소인 TRP-1, MMP-1과 MMP-9의 mRNA 발현 감소효과를 나타낸 위스턴 블롯이며, 도 13b는 상기 도 13a를 정량적으로 나타낸 그래프이다. 13a is a Wiston blot showing the effect of reducing the mRNA expression of TRP-1, MMP-1 and MMP-9, which are major enzymes for melanogenesis and collagen degradation, using the ultrasonic extract of worms prepared according to Example 12 of the present invention; , and FIG. 13B is a graph quantitatively illustrating FIG. 13A.
도 13a 및 도 13b에 도시된 바와 같이, 실시예 12의 지충이 초음파 추출물을 흑색종양세포인 B16F0에 농도별로 처리한 후 멜라닌 생성과 콜라겐 분해의 주요효소인 TRP-1, MMP-1과 MMP-9의 mRNA 발현 감소효과를 평가한 결과, 실시예 12의 추출물은 대조군(미처리군)에 비해 1 mg/mL과 2 mg/mL 처리군에서 농도가 증가함에 따라 TRP-1의 발현을 유의하게 감소시킴을 확인하였다(p<0.05).13A and 13B, after treating the ultrasonic extract of Example 12 with B16F0, a melanoma cell, by concentration, TRP-1, MMP-1 and MMP-, which are major enzymes for melanogenesis and collagen degradation, As a result of evaluating the mRNA expression reduction effect of 9, the extract of Example 12 significantly reduced the expression of TRP-1 as the concentration increased in the 1 mg/mL and 2 mg/mL treatment groups compared to the control group (untreated group) Sikkim was confirmed ( p <0.05).
또한, 실시예 12의 지충이 초음파 추출물에 의한 MMP-1과 MMP-9의 발현 역시 추출물 농도 의존적으로 감소하는 것을 확인하였다. MMP-1의 발현은 대조군과 비교했을 때 2 mg/mL 처리군에서 58.6%의 발현 억제를 보였으며 MMP-9는 2 mg/mL 처리군에서 78.8%의 저해능을 확인하였다. In addition, it was confirmed that the expression of MMP-1 and MMP-9 by the ultrasonic extract of the worm of Example 12 also decreased in an extract concentration-dependent manner. The expression of MMP-1 showed an expression inhibition of 58.6% in the 2 mg/mL treatment group compared to the control group, and MMP-9 showed an inhibitory ability of 78.8% in the 2 mg/mL treatment group.
이러한 결과를 통해 최적 추출조건으로 추출한 지충이 초음파 추출물이 B16F0에서 TRP-1, MMP-1과 MMP-9의 mRNA 발현을 효과적으로 저해하여 멜라닌 생성과 콜라겐 분해를 억제할 수 있음이 확인하였다.Through these results, it was confirmed that the ultrasonic extract of worms extracted under the optimal extraction conditions effectively inhibited the mRNA expression of TRP-1, MMP-1 and MMP-9 in B16F0, thereby inhibiting melanin production and collagen degradation.
하기에 본 발명의 분말을 함유하는 조성물의 제제예를 설명하나, 본 발명은 이를 한정하고자 함이 아닌 단지 구체적으로 설명하고자 함이다.Hereinafter, formulation examples of the composition containing the powder of the present invention will be described, but the present invention is not intended to limit the present invention, but merely to describe it in detail.
제제예 1. 과립제의 제조Formulation Example 1. Preparation of granules
실시예 12에서 얻은 추출물 분말 1,000 mg1,000 mg of extract powder obtained in Example 12
비타민 혼합물 적량appropriate amount of vitamin mixture
비타민 A 아세테이트 70 ㎍70 μg vitamin A acetate
비타민 E 1.0 mgVitamin E 1.0 mg
비타민 B1 0.13 mgVitamin B1 0.13 mg
비타민 B2 0.15 mgVitamin B2 0.15 mg
비타민 B6 0.5 mg0.5 mg of vitamin B6
비타민 B12 0.2 ㎍0.2 μg of vitamin B12
비타민 C 10 mg
비오틴 10 ㎍Biotin 10 μg
니코틴산아미드 1.7 mgNicotinamide 1.7 mg
엽산 50 ㎍50 μg of folic acid
판토텐산 칼슘 0.5 mgCalcium pantothenate 0.5 mg
무기질 혼합물 적량Mineral mixture appropriate amount
황산제1철 1.75 mgferrous sulfate 1.75 mg
산화아연 0.82 mgZinc Oxide 0.82 mg
탄산마그네슘 25.3 mgMagnesium carbonate 25.3 mg
제1인산칼륨 15 mgPotassium monophosphate 15 mg
제2인산칼슘 55 mgDibasic calcium phosphate 55 mg
구연산칼륨 90 mg
탄산칼슘 100 mg100 mg of calcium carbonate
염화마그네슘 24.8 mgMagnesium chloride 24.8 mg
상기의 비타민 및 미네랄 혼합물의 조성비는 비교적 과립제에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 그 배합비를 임의로 변형 실시하여도 무방하며, 통상의 과립제 제조방법에 따라 상기의 성분을 혼합한 다음, 과립을 제조하고, 통상의 방법에 따라 건강기능식품 조성물 제조에 사용할 수 있다.The composition ratio of the vitamin and mineral mixture is relatively suitable for granules in a preferred embodiment, but the mixing ratio may be arbitrarily modified. It can be prepared and used in the preparation of a health functional food composition according to a conventional method.
제제예 2. 기능성 음료의 제조Formulation Example 2. Preparation of functional beverage
실시예 12에서 얻은 추출물 분말 1,000 mg1,000 mg of extract powder obtained in Example 12
구연산 1,000 mg1,000 mg citric acid
올리고당 100 g100 g of oligosaccharides
매실농축액 2 g2 g of plum concentrate
타우린 1 g1 g taurine
정제수를 가하여 전체 900 mLAdd purified water to total 900 mL
통상의 건강음료 제조방법에 따라 상기의 성분을 혼합한 다음, 약 1 시간 동안 85 ℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 2 L 용기에 취득하여 밀봉 멸균한 뒤 냉장 보관한 다음 본 발명의 기능성 음료 조성물 제조에 사용한다. After mixing the above ingredients according to a conventional health drink manufacturing method, after stirring and heating at 85 ° C for about 1 hour, the resulting solution is filtered and obtained in a sterilized 2 L container, sealed and sterilized, then refrigerated. It is used to prepare the functional beverage composition of the present invention.
상기 조성비는 비교적 기호음료에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 수요계층, 수요국가, 사용용도 등 지역적, 민족적 기호도에 따라서 그 배합비를 임의로 변형 실시하여도 무방하다.Although the composition ratio is prepared by mixing ingredients suitable for relatively favorite beverages in a preferred embodiment, the mixing ratio may be arbitrarily modified according to regional and national preferences such as demand class, demanding country, and use.
본 발명을 적용하기에 적합한 화장료 조성물의 제조예를 제시하기로 한다.A preparation example of a cosmetic composition suitable for applying the present invention will be presented.
제조예 3: 화장수Preparation example 3: lotion
실시예 12의 지충이 초음파 추출물을 포함하는 화장료 중 화장수의 제조예는 하기 표 5와 같다.Table 5 below shows the preparation examples of the lotion among the cosmetics containing the ultrasonic extract of the worm of Example 12.
제조예 4: 로션Preparation Example 4: Lotion
실시예 12의 지충이 초음파 추출물을 포함하는 화장료 중 로션의 제조예는 하기 표 6과 같다.Table 6 below shows the preparation examples of the lotion in the cosmetic containing the worm worm ultrasonic extract of Example 12.
제조예 5: 영양 크림Preparation 5: Nourishing Cream
실시예 12의 지충이 초음파 추출물을 포함하는 화장료 중 영양 크림의 제조예는 하기 표 7과 같다.Table 7 below shows a preparation example of a nutritious cream in a cosmetic containing the worm worm ultrasonic extract of Example 12.
제조예 6: 에센스Preparation Example 6: Essence
실시예 12의 지충이 초음파 추출물을 포함하는 화장료 중 에센스의 제조예는 하기 표 8과 같다.Table 8 below shows the preparation examples of the essence in the cosmetic containing the worm worm ultrasonic extract of Example 12.
제조예 7: 마스크 팩용 유액Preparation Example 7: Emulsion for mask pack
실시예 12의 지충이 초음파 추출물을 포함하는 화장료 중 마스크 팩용 유액의 제조예는 하기 표 9와 같다.Preparation examples of the emulsion for the mask pack among the cosmetics containing the ultrasonic extract of the worm of Example 12 are shown in Table 9 below.
Claims (9)
(B) 상기 (A)단계의 실험값을 이용하여 하기 [수학식 1]로 표시되는 2차 회귀식 모델을 도출하는 단계;
(C) 상기 (B)단계에서 도출된 2차 회귀식 모델을 변량분석(ANOVA)하여 신뢰도를 입증하고 상기 추출조건에 대한 반응표면곡선을 수득하는 단계;
(D) 상기 (A)단계에서 수득한 상등액의 총 플라보노이드 함량에 대한 실험값을 획득하는 단계;
(E) 상기 (D)단계의 실험값을 이용하여 하기 [수학식 2]로 표시되는 2차 회귀식 모델을 도출하는 단계;
(F) 상기 (E)단계에서 도출된 2차 회귀식 모델을 변량분석(ANOVA)하여 신뢰도를 입증하고 상기 추출조건에 대한 반응표면곡선을 수득하는 단계;
(G) 상기 (A)단계에서 수득한 상등액의 DPPH 라디칼 소거능에 대한 실험값을 획득하는 단계;
(H) 상기 (G)단계의 실험값을 이용하여 하기 [수학식 3]으로 표시되는 2차 회귀식 모델을 도출하는 단계;
(I) 상기 (H)단계에서 도출된 2차 회귀식 모델을 변량분석(ANOVA)하여 신뢰도를 입증하고 상기 추출조건에 대한 반응표면곡선을 수득하는 단계;
(J) 상기 (A)단계에서 수득한 상등액의 티로시나제 억제능에 대한 실험값을 획득하는 단계;
(K) 상기 (J)단계의 실험값을 이용하여 하기 [수학식 4]로 표시되는 2차 회귀식 모델을 도출하는 단계;
(L) 상기 (K)단계에서 도출된 2차 회귀식 모델을 변량분석(ANOVA)하여 신뢰도를 입증하고 상기 추출조건에 대한 반응표면곡선을 수득하는 단계;
(M) 상기 (A)단계에서 수득한 상등액의 콜라게나제 억제능에 대한 실험값을 획득하는 단계;
(N) 상기 (M)단계의 실험값을 이용하여 하기 [수학식 5]로 표시되는 2차 회귀식 모델을 도출하는 단계;
(O) 상기 (M)단계에서 도출된 2차 회귀식 모델을 변량분석(ANOVA)하여 신뢰도를 입증하고 상기 추출조건에 대한 반응표면곡선을 수득하는 단계; 및
(P) 상기 (C), (F), (I), (L) 및 (O)단계에서 수득된 반응표면곡선을 겹치기기법(superimposing)으로 총 폴리페놀 함량, 총 플라보노이드 함량, DPPH 라디칼 소거능, 티로시나제 억제능 및 콜라게나제 억제능에 대한 공통의 최적화 조건을 예측하는 단계;를 포함하는 것을 특징으로 하는 반응표면분석법을 이용한 지충이 초음파 추출물의 제조방법;
[수학식 1]
YTPC=+11.87710-0.27813X1+0.062526X2-0.10999X3-0.038357X1 2+0.011033X1X2-8.04762E-004X2 2+9.16875E-003X1X3-2.72059E-004X2X3-9.82967E-004X3 2
[수학식 2]
YTFC=+0.29505-0.027059X1-3.97311E-003X2+2.06369E-003X3+6.56102E-004X1 2+2.35575E-004X1X2+1.4523E-005X2 2-5.60826E-005X1X3+4.47917E-005X2X3-9.59741E-006X3 2
[수학식 3]
YDPPH=-12.01377-0.23738X1+1.10578X2+1.88331X3-0.18487X1 2+0.065359X1X2-0.015823X2 2+0.018519X1X3+6.53596E-003X2X3-0.027340X3 2
[수학식 4]
YTI=+21.89570+2.31910X1+0.73168X2+0.89582X3-0.10956X1 2+6.37868E-003X1X2-7.16647E-003X2 2-1.71875E-003X1X3+2.17402E-003X2X3-7.54092EX3 2
[수학식 5]
YCI=7.18898+0.47210X1+1.74516X2+1.05430X3-0.20030X1 2+0.036374X1X2-0.013524X2 2+0.042529X1X3-7.41903E-003X2X3-8.53821E-003X3 2
상기 수학식 1 내지 5에서, YTPC는 총 폴리페놀 함량(mg GAE/g DM), YTFC는 총 플라보노이드 함량(mg QE/g DM), YDPPH는 DPPH 라디칼 소거능 예측값(%), YTI는 티로시나제 억제능 예측값(%), YCI는 콜라게나제 억제능 예측값(%), X1은 추출시간, X2는 추출온도, X3는 추출용매의 농도임.(A) Water, an extraction solvent that is a lower alcohol having 1 to 4 carbon atoms or a mixed solvent thereof, extraction temperature of 20 to 85 ° C., extraction time of 5 to 30 minutes under extraction conditions of 20 to 50 kHz frequency ultrasonicator after extraction obtaining an experimental value for the total polyphenol content of the supernatant obtained by centrifugation;
(B) deriving a quadratic regression model represented by the following [Equation 1] using the experimental value of step (A);
(C) verifying reliability by performing analysis of variance (ANOVA) on the quadratic regression model derived in step (B), and obtaining a response surface curve for the extraction conditions;
(D) obtaining an experimental value for the total flavonoid content of the supernatant obtained in step (A);
(E) deriving a quadratic regression model represented by the following [Equation 2] using the experimental value of step (D);
(F) verifying reliability by performing analysis of variance (ANOVA) on the quadratic regression model derived in step (E), and obtaining a response surface curve for the extraction conditions;
(G) obtaining an experimental value for the DPPH radical scavenging ability of the supernatant obtained in step (A);
(H) deriving a quadratic regression model represented by the following [Equation 3] using the experimental values of the step (G);
(I) verifying reliability by performing analysis of variance (ANOVA) on the quadratic regression model derived in step (H), and obtaining a response surface curve for the extraction conditions;
(J) obtaining an experimental value for the tyrosinase inhibitory ability of the supernatant obtained in step (A);
(K) deriving a quadratic regression model represented by the following [Equation 4] using the experimental values of the step (J);
(L) verifying reliability by performing analysis of variance (ANOVA) on the quadratic regression model derived in step (K), and obtaining a response surface curve for the extraction conditions;
(M) obtaining an experimental value for the collagenase inhibitory ability of the supernatant obtained in step (A);
(N) deriving a quadratic regression model represented by the following [Equation 5] using the experimental values of the step (M);
(O) verifying reliability by performing analysis of variance (ANOVA) on the quadratic regression model derived in step (M), and obtaining a response surface curve for the extraction conditions; and
(P) Total polyphenol content, total flavonoid content, DPPH radical scavenging ability by superimposing the reaction surface curves obtained in steps (C), (F), (I), (L) and (O) Predicting common optimization conditions for tyrosinase inhibitory activity and collagenase inhibitory activity;
[Equation 1]
Y TPC =+11.87710-0.27813X 1 +0.062526X 2 -0.10999X 3 -0.038357X 1 2 +0.011033X 1 X 2 -8.04762E-004X 2 2 +9.16875E-003X 1 X 3 -2.72059E-004X 2 X 3 -9.82967E-004X 3 2
[Equation 2]
Y TFC =+0.29505-0.027059X 1 -3.97311E-003X 2 +2.06369E-003X 3 +6.56102E-004X 1 2 +2.35575E-004X 1 X 2 +1.4523E-005X 2 2 -5.60826E-005X 1 X 3 +4.47917E-005X 2 X 3 -9.59741E-006X 3 2
[Equation 3]
Y DPPH =-12.01377-0.23738X 1 +1.10578X 2 +1.88331X 3 -0.18487X 1 2 +0.065359X 1 X 2 -0.015823X 2 2 +0.018519X 1 X 3 +6.53596E-003X 2 X 3 -0.027340X 3 2
[Equation 4]
Y TI =+21.89570+2.31910X 1 +0.73168X 2 +0.89582X 3 -0.10956X 1 2 +6.37868E-003X 1 X 2 -7.16647E-003X 2 2 -1.71875E-003X 1 X 3 +2.17402E-003X 2 X 3 -7.54092EX 3 2
[Equation 5]
Y CI =7.18898+0.47210X 1 +1.74516X 2 +1.05430X 3 -0.20030X 1 2 +0.036374X 1 X 2 -0.013524X 2 2 +0.042529X 1 X 3 -7.41903E-003X 2 X 3 -8.53821E- 003X 3 2
In Equations 1 to 5, Y TPC is the total polyphenol content (mg GAE/g DM), Y TFC is the total flavonoid content (mg QE/g DM), Y DPPH is the DPPH radical scavenging activity predicted value (%), Y TI is the predicted value of tyrosinase inhibition (%), Y CI is the predicted value of the inhibition of collagenase (%), X 1 is the extraction time, X 2 is the extraction temperature, and X 3 is the concentration of the extraction solvent.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200098684 | 2020-08-06 | ||
KR20200098684 | 2020-08-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20220018448A true KR20220018448A (en) | 2022-02-15 |
Family
ID=80325552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210103606A KR20220018448A (en) | 2020-08-06 | 2021-08-06 | Compositions containing Sargassum thunbergii extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20220018448A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101094890B1 (en) | 2010-01-27 | 2011-12-15 | 재단법인 제주테크노파크 | Compositions for Promotion of Collagen synthesis |
KR101727788B1 (en) | 2014-11-06 | 2017-04-18 | 전라남도 | Sargassum thunbergii hydrolysates that have high glucuronic acid cotent, preparation method thereof and antiaging cosmetic composition containing the same |
-
2021
- 2021-08-06 KR KR1020210103606A patent/KR20220018448A/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101094890B1 (en) | 2010-01-27 | 2011-12-15 | 재단법인 제주테크노파크 | Compositions for Promotion of Collagen synthesis |
KR101727788B1 (en) | 2014-11-06 | 2017-04-18 | 전라남도 | Sargassum thunbergii hydrolysates that have high glucuronic acid cotent, preparation method thereof and antiaging cosmetic composition containing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101201916B1 (en) | Preparing method for fagopyrum tataricym sprout extracts using enzyme reaction and cosmetic composition containing the same | |
KR102479408B1 (en) | Compositions containing Sargassum horneri (Turner) C. Agardh extract | |
KR20170048904A (en) | Cosmetic compositions for skin whitening containing costunolide from natural extracts | |
KR102399204B1 (en) | Compositions containing black garlic extract | |
KR100926073B1 (en) | The skin beautifing cosmetic composition containing vitamin C and the extract of Opuntia ficus-indica L. var. saboten Makino flowers | |
KR102425559B1 (en) | Composition for improving skin comprising an extract of Pueraria thomsonii or a compound derived therefrom | |
KR102414390B1 (en) | A composition for antioxidating, whitening and improving wrinkle comprising flower extract | |
KR102639155B1 (en) | Composition for skin improvement containing valechlorine | |
KR102629000B1 (en) | Composition for skin improvement containing Salvianolic acid C | |
KR102358319B1 (en) | Sunscreen cosmetic composition comprising chestnut inner skin extract | |
KR102449136B1 (en) | Compositions containing Taraxacum coreanum extract | |
KR20220018448A (en) | Compositions containing Sargassum thunbergii extract | |
KR102030419B1 (en) | A composition comprising graviola having inhibitory effect on induction of grey hair and positive effect on induction of black hair | |
KR20160147136A (en) | A composition for skin whitening or regeneration comprising Melandrium firmum extract | |
KR20210004155A (en) | Composition for improving winkle or skin whitening comprising coreopsis lanceolate l. extract | |
KR102307176B1 (en) | compositions containing by-product extract of Allium sativum L. | |
KR102293782B1 (en) | Compositions containing peanut shell extract | |
KR20240003564A (en) | Compositions containing Orostachydis Herba extract | |
KR102296938B1 (en) | Antioxidant composition comprising veronica longifolia | |
KR102236021B1 (en) | Composition for skin whitening or improving winkle comprising hemiptelea davidii extract | |
KR102636983B1 (en) | Composition for skin improvement containing isodemethylwedelolactone | |
KR20070065665A (en) | Whitening cosmetic composition | |
KR102665307B1 (en) | Composition for skin improvement containing acetylcimigenol arabinoside | |
KR102628373B1 (en) | Composition for skin improvement containing dracorhodin perochlorate | |
KR102662256B1 (en) | Composition for skin improvement containing Syringaresnol-4-O-β-D-apiofuranosy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |